{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:47:37Z","timestamp":1782488857698,"version":"3.54.5"},"reference-count":825,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":167,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2022LNJJ10"],"award-info":[{"award-number":["2022LNJJ10"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018806","name":"Department of Science and Technology of Hubei Province","doi-asserted-by":"publisher","award":["CXPJJH121005-01"],"award-info":[{"award-number":["CXPJJH121005-01"]}],"id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Military Medical Research"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.mmr.2026.100047","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T12:58:32Z","timestamp":1781960312000},"page":"100047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances"],"prefix":"10.1016","volume":"13","author":[{"given":"Gui-Long","family":"Tanzhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-Yang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Michael","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R","family":"Lockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10412","key":"10.1016\/j.mmr.2026.100047_bib1","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib2","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain tumor microenvironment and host state: Implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40478-024-01895-9","article-title":"An immune scoring system predicts prognosis and immune characteristics in lung adenocarcinoma brain metastases by RNA sequencing","volume":"12","author":"Xiao","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.mmr.2026.100047_bib4","article-title":"National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020","volume":"34","author":"Xiao","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib7","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.3390\/ijms24119256","article-title":"Exploring the functional roles of telomere maintenance 2 in the tumorigenesis of glioblastoma multiforme and drug responsiveness to temozolomide","volume":"24","author":"Feng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mmr.2026.100047_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.779168","article-title":"Molecular subtypes and prognostic signature of pyroptosis-related lncRNAs in glioma patients","volume":"12","author":"Tanzhu","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib9","article-title":"Metastatic brain tumors: from development to cutting-edge treatment","volume":"6","author":"Tanzhu","year":"2025","journal-title":"MedComm (2020)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.21147\/j.issn.1000-9604.2025.06.04","article-title":"Cancer statistics in China: epidemiology, risk factors, and prevention","volume":"37","author":"Cao","year":"2025","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/joim.13469","article-title":"Central nervous system zoning: How brain barriers establish subdivisions for CNS immune privilege and immune surveillance","volume":"292","author":"Proulx","year":"2022","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib14","first-page":"58","article-title":"Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br J Exp Pathol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41577-025-01175-0","article-title":"Redefining CNS immune privilege","volume":"25","author":"Smyth","year":"2025","journal-title":"Nat Rev Immunol"},{"issue":"6640","key":"10.1016\/j.mmr.2026.100047_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo7649","article-title":"Transforming the understanding of brain immunity","volume":"380","author":"Castellani","year":"2023","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"issue":"147","key":"10.1016\/j.mmr.2026.100047_bib18","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7560","key":"10.1016\/j.mmr.2026.100047_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mmr.2026.100047_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102986","article-title":"Cerebral glymphatic system: structure, regulation, ageing, and mechanisms of encephalopathy","volume":"114","author":"Zhao","year":"2026","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.mmr.2026.100047_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102900","article-title":"Glymphatic system and intracerebral hemorrhage: Identifying molecular targets for future therapeutic advancements","volume":"112","author":"Mukherjee","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10571-025-01598-2","article-title":"The cerebral lymphatic system: function, controversies, and therapeutic approaches for central nervous system diseases","volume":"45","author":"Pan","year":"2025","journal-title":"Cell Mol Neurobiol"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib24","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.7150\/thno.111972","article-title":"Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies","volume":"15","author":"Wen","year":"2025","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41422-022-00639-5","article-title":"Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity","volume":"32","author":"Zhou","year":"2022","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.mmr.2026.100047_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.21147\/j.issn.1000-9604.2025.03.12","article-title":"Tumor-educated cells in tumor microenvironment: key drivers of immunotherapy resistance","volume":"37","author":"Zou","year":"2025","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","article-title":"Transcriptome analysis reveals tumor microenvironment changes in glioblastoma","volume":"41","author":"Hoogstrate","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-051122-110348","article-title":"Role of the microenvironment in glioma pathogenesis","volume":"19","author":"Jayaram","year":"2024","journal-title":"Annu Rev Pathol"},{"issue":"17","key":"10.1016\/j.mmr.2026.100047_bib32","article-title":"Tumor-associated macrophage-derived exosomal LINC01232 induces the immune escape in glioma by decreasing surface MHC-I expression","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1158\/0008-5472.CAN-22-1570","article-title":"Phagocytosis of glioma cells enhances the immunosuppressive phenotype of bone marrow-derived macrophages","volume":"83","author":"Wu","year":"2023","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ccell.2023.12.018","article-title":"Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms","volume":"42","author":"Bejarano","year":"2024","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41583-023-00684-y","article-title":"Shaping the brain vasculature in development and disease in the single-cell era","volume":"24","author":"W\u00e4lchli","year":"2023","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41419-023-05788-y","article-title":"CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR\/PI3K pathway","volume":"14","author":"Mao","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","article-title":"Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00018-023-04944-z","article-title":"Critical functions of extracellular matrix in brain metastasis seeding","volume":"80","author":"Yuzhalin","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41419-023-05823-y","article-title":"Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"issue":"7948","key":"10.1016\/j.mmr.2026.100047_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib42","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-025-03530-z","article-title":"Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases","volume":"31","author":"Tagore","year":"2025","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib44","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.immuni.2025.03.021","article-title":"Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies","volume":"58","author":"Galvez-Cancino","year":"2025","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"Pt A","key":"10.1016\/j.mmr.2026.100047_bib47","article-title":"Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis","volume":"142","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib48","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","article-title":"Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective","volume":"187","author":"Mathur","year":"2024","journal-title":"Cell"},{"issue":"6190","key":"10.1016\/j.mmr.2026.100047_bib49","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100636","article-title":"Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression","volume":"7","author":"Giannoudis","year":"2022","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib51","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.7150\/ijbs.109187","article-title":"SEC61G facilitates brain metastases via antagonizing PGAM1 ubiquitination and immune microenvironment remodeling in non-small cell lung cancer","volume":"21","author":"Zhou","year":"2025","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib52","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1002\/tox.24231","article-title":"Exploring the impact of ITGB2 on glioma progression and treatment: Insights from non-apoptotic cell death and immunotherapy","volume":"39","author":"Zhuang","year":"2024","journal-title":"Environ Toxicol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib53","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41556-024-01446-3","article-title":"Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3","volume":"26","author":"Seehawer","year":"2024","journal-title":"Nat Cell Biol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jid.2023.01.011","article-title":"Identification of epigenetically regulated genes distinguishing intracranial from extracranial melanoma metastases","volume":"143","author":"Westphal","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib55","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/acs.jproteome.9b00664","article-title":"Comparative membrane N-glycomics of different breast cancer cell lines to understand breast cancer brain metastasis","volume":"19","author":"Peng","year":"2020","journal-title":"J Proteome Res"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib56","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.neuron.2024.10.012","article-title":"Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence","volume":"112","author":"Xie","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer stem cell mimicry for immune evasion and therapeutic resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib59","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.7150\/thno.82590","article-title":"SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages","volume":"13","author":"Fan","year":"2023","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccell.2020.06.003","article-title":"Cell lineage-based stratification for glioblastoma","volume":"38","author":"Wang","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib61","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.ymthe.2021.10.028","article-title":"FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9\/CYLD\/NF-\u03baB axis","volume":"30","author":"Chen","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.mmr.2026.100047_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104239","article-title":"Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM","volume":"83","author":"Xiong","year":"2022","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","article-title":"Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma","volume":"39","author":"Hara","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib64","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-024-01755-6","article-title":"Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth","volume":"12","author":"Nicholson","year":"2024","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib65","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/neuonc\/noae090","article-title":"SMYD2 induced PGC1\u03b1 methylation promotes stemness maintenance of glioblastoma stem cells","volume":"26","author":"Li","year":"2024","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib66","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/neuonc\/noae147","article-title":"A low level of tumor necrosis factor \u03b1 in tumor microenvironment maintains the self-renewal of glioma stem cells by Vasorin-mediated glycolysis","volume":"26","author":"Zhang","year":"2024","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib67","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41418-024-01292-8","article-title":"Ifi35 regulates non-canonical NF-\u03baB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophages","volume":"31","author":"Li","year":"2024","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib68","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/2159-8290.CD-23-1348","article-title":"Phosphocreatine promotes epigenetic reprogramming to facilitate glioblastoma growth through stabilizing BRD2","volume":"14","author":"Chen","year":"2024","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib69","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/0008-5472.CAN-24-1412","article-title":"PTBP1 lactylation promotes glioma stem cell maintenance through PFKFB4-driven glycolysis","volume":"85","author":"Zhou","year":"2025","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ccell.2024.12.006","article-title":"Infiltrating plasma cells maintain glioblastoma stem cells through IgG-tumor binding","volume":"43","author":"Gao","year":"2025","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib71","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/0008-5472.CAN-21-3629","article-title":"CHI3L1 is a modulator of glioma stem cell states and a therapeutic target in glioblastoma","volume":"83","author":"Guetta-Terrier","year":"2023","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib72","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/neuonc\/noac063","article-title":"USF1\/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion","volume":"24","author":"Zhou","year":"2022","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib73","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.cell.2021.03.023","article-title":"Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion","volume":"184","author":"Gangoso","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib74","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ccell.2023.07.012","article-title":"CD44+ lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration","volume":"41","author":"Huang","year":"2023","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib75","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/cns.14191","article-title":"G9a promotes immune suppression by targeting the Fbxw7\/Notch pathway in glioma stem cells","volume":"29","author":"Cao","year":"2023","journal-title":"CNS Neurosci Ther"},{"issue":"31","key":"10.1016\/j.mmr.2026.100047_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3984","article-title":"Multiomics analyses reveal DARS1-AS1\/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis\/radioresistance","volume":"9","author":"Zheng","year":"2023","journal-title":"Sci Adv"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib77","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.7150\/ijbs.102051","article-title":"SUMOylation modification of HNRNPK at the K422 site promotes invasion in glioblastoma","volume":"20","author":"Zhao","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib78","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1002\/tox.24407","article-title":"Epigenetic regulation of RNF135 by LSD1 promotes stemness maintenance and brain metastasis in lung adenocarcinoma","volume":"39","author":"Qu","year":"2024","journal-title":"Environ Toxicol"},{"issue":"739","key":"10.1016\/j.mmr.2026.100047_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg5553","article-title":"Reactivating PTEN to impair glioma stem cells by inhibiting cytosolic iron-sulfur assembly","volume":"16","author":"Yin","year":"2024","journal-title":"Sci Transl Med"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib80","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1158\/1078-0432.CCR-22-3273","article-title":"Dual role of CXCL8 in maintaining the mesenchymal state of glioblastoma stem cells and M2-like tumor-associated macrophages","volume":"29","author":"Yuan","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"698","key":"10.1016\/j.mmr.2026.100047_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade8732","article-title":"Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas","volume":"15","author":"Kanaya","year":"2023","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib82","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/1878-0261.13453","article-title":"Extracellular IGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma","volume":"17","author":"Dufrusine","year":"2023","journal-title":"Mol Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib83","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1002\/tox.24328","article-title":"CircVCAN promotes glioma progression through the miR-488-3p\/MEF2C-JAGGED1 axis","volume":"39","author":"Yang","year":"2024","journal-title":"Environ Toxicol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.stem.2019.11.015","article-title":"Outer radial Glia-like cancer stem cells contribute to heterogeneity of glioblastoma","volume":"26","author":"Bhaduri","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib85","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1158\/2159-8290.CD-23-0012","article-title":"Chd2 regulates neuron-glioma interactions in pediatric glioma","volume":"14","author":"Zhang","year":"2024","journal-title":"Cancer Discov"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167725","article-title":"A brain-tumor neural circuit controls breast cancer progression in mice","volume":"133","author":"Xiong","year":"2023","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib87","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s12264-023-01028-7","article-title":"Neuronal mechanisms govern glioblastoma cell invasion","volume":"39","author":"Lin","year":"2023","journal-title":"Neurosci Bull"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib88","first-page":"26","article-title":"A new brain-tumor neural circuit","volume":"53","author":"Le Bras","year":"2024","journal-title":"Lab Anim (NY)"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib89","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neuron.2023.01.013","article-title":"Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation","volume":"111","author":"Curry","year":"2023","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib90","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neuron.2024.12.026","article-title":"Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition","volume":"113","author":"Goldberg","year":"2025","journal-title":"Neuron"},{"issue":"7961","key":"10.1016\/j.mmr.2026.100047_bib91","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41586-023-06036-1","article-title":"Glioblastoma remodelling of human neural circuits decreases survival","volume":"617","author":"Krishna","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib92","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","volume":"185","author":"Varn","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib93","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41591-024-02969-w","article-title":"A prognostic neural epigenetic signature in high-grade glioma","volume":"30","author":"Drexler","year":"2024","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib94","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s43018-023-00626-8","article-title":"A designer peptide against the EAG2-Kv\u03b22 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma","volume":"4","author":"Dong","year":"2023","journal-title":"Nat Cancer"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib95","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/brain\/awaa408","article-title":"Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma","volume":"144","author":"Hong","year":"2021","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.mmr.2026.100047_bib96","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","article-title":"Glioblastoma hijacks neuronal mechanisms for brain invasion","volume":"185","author":"Venkataramani","year":"2022","journal-title":"Cell"},{"issue":"7793","key":"10.1016\/j.mmr.2026.100047_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu","year":"2020","journal-title":"Nature"},{"issue":"7971","key":"10.1016\/j.mmr.2026.100047_bib98","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41586-023-06267-2","article-title":"Remote neuronal activity drives glioma progression through SEMA4F","volume":"619","author":"Huang-Hobbs","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib99","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1158\/0008-5472.CAN-23-0609","article-title":"Neuronal activity promotes glioma progression by inducing proneural-to-mesenchymal transition in glioma stem cells","volume":"84","author":"Guo","year":"2024","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib100","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/ijms24043242","article-title":"Coculture with neural stem cells may shift the transcription profile of glioblastoma multiforme towards cancer-specific stemness","volume":"24","author":"Vaidya","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"50","key":"10.1016\/j.mmr.2026.100047_bib101","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2417420121","article-title":"Widespread neuroanatomical integration and distinct electrophysiological properties of glioma-innervating neurons","volume":"121","author":"Hsieh","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6783","key":"10.1016\/j.mmr.2026.100047_bib102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/35012083","article-title":"Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus","volume":"405","author":"Bergles","year":"2000","journal-title":"Nature"},{"issue":"7071","key":"10.1016\/j.mmr.2026.100047_bib103","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04302","article-title":"NMDA receptors are expressed in oligodendrocytes and activated in ischaemia","volume":"438","author":"K\u00e1rad\u00f3ttir","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mmr.2026.100047_bib104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28080","article-title":"Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival","volume":"6","author":"Kougioumtzidou","year":"2017","journal-title":"Elife"},{"issue":"7775","key":"10.1016\/j.mmr.2026.100047_bib105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"issue":"7775","key":"10.1016\/j.mmr.2026.100047_bib106","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-025-02009-9","article-title":"Neurotransmitter power plays: the synaptic communication nexus shaping brain cancer","volume":"13","author":"Mondal","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib108","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166271","article-title":"Exosomal TNF-\u03b1 mediates voltage-gated Na+ channel 1.6 overexpression and contributes to brain tumor-induced neuronal hyperexcitability","volume":"134","author":"Sanchez Trivino","year":"2024","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuron.2024.10.016","article-title":"Potassium ion channel modulation at cancer-neural interface enhances neuronal excitability in epileptogenic glioblastoma multiforme","volume":"113","author":"Zhang","year":"2025","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib110","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1474-4422(24)00160-1","article-title":"Glioblastoma and brain connectivity: the need for a paradigm shift","volume":"23","author":"Salvalaggio","year":"2024","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib111","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib112","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.ccell.2025.07.024","article-title":"Long-range cholinergic input promotes glioblastoma progression","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"28","key":"10.1016\/j.mmr.2026.100047_bib113","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103505118","article-title":"VLM catecholaminergic neurons control tumor growth by regulating CD8+ T cells","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8056","key":"10.1016\/j.mmr.2026.100047_bib114","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","volume":"639","author":"Barron","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/onc.2016.245","article-title":"Endogenous GABAA receptor activity suppresses glioma growth","volume":"36","author":"Blanchart","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib116","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s13287-022-03087-5","article-title":"Propofol enhances stem-like properties of glioma via GABAAR-dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism","volume":"13","author":"Fan","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"8056","key":"10.1016\/j.mmr.2026.100047_bib117","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","volume":"639","author":"Barron","year":"2025","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib118","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.3390\/cancers14102544","article-title":"Prognostic neurotransmitter receptors genes are associated with immune response, inflammation and cancer hallmarks in brain tumors","volume":"14","author":"Belotti","year":"2022","journal-title":"Cancers"},{"issue":"7775","key":"10.1016\/j.mmr.2026.100047_bib119","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"issue":"46","key":"10.1016\/j.mmr.2026.100047_bib120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108959118","article-title":"Functional alterations in cortical processing of speech in glioma-infiltrated cortex","volume":"118","author":"Aabedi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib121","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/imm.13581","article-title":"BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis","volume":"168","author":"Yu","year":"2023","journal-title":"Immunology"},{"issue":"7986","key":"10.1016\/j.mmr.2026.100047_bib122","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib123","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/s41467-024-48740-0","article-title":"Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis","volume":"15","author":"Ruan","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib124","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ccell.2024.05.006","article-title":"Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib125","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/neuonc\/noab290","article-title":"Neuronal exposure induces neurotransmitter signaling and synaptic mediators in tumors early in brain metastasis","volume":"24","author":"Deshpande","year":"2022","journal-title":"Neuro Oncol"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib126","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.cell.2024.07.030","article-title":"Macrophage-mediated myelin recycling fuels brain cancer malignancy","volume":"187","author":"Kloosterman","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib127","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41467-020-15770-3","article-title":"Midkine activation of CD8+ T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth","volume":"11","author":"Guo","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib128","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/neuonc\/noae054","article-title":"NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma","volume":"26","author":"Anastasaki","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib129","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1038\/s41467-022-34175-y","article-title":"Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma","volume":"13","author":"Tomaszewski","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.mmr.2026.100047_bib130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2024.09.003","article-title":"Brain-tumor-seeking and serpin-inhibiting outer membrane vesicles restore plasmin-mediated attacks against brain metastases","volume":"375","author":"Zhou","year":"2024","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib131","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2024.11.002","article-title":"Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing","volume":"188","author":"Tetzlaff","year":"2025","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.mmr.2026.100047_bib132","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib133","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/jcbfm.2011.149","article-title":"Sweet sixteen for ANLS","volume":"32","author":"Pellerin","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7638","key":"10.1016\/j.mmr.2026.100047_bib134","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1101\/gad.188326.112","article-title":"Astrocytes and disease: a neurodevelopmental perspective","volume":"26","author":"Molofsky","year":"2012","journal-title":"Genes Dev"},{"issue":"7999","key":"10.1016\/j.mmr.2026.100047_bib136","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41586-023-06935-3","article-title":"A molecular switch for neuroprotective astrocyte reactivity","volume":"626","author":"Cameron","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib137","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10555-025-10276-0","article-title":"Astrocyte involvement in brain metastasis: from biological mechanisms to therapeutic strategies","volume":"44","author":"Zhou","year":"2025","journal-title":"Cancer Metastasis Rev"},{"issue":"8078","key":"10.1016\/j.mmr.2026.100047_bib138","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41586-025-09191-9","article-title":"Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions","volume":"644","author":"Andersen","year":"2025","journal-title":"Nature"},{"issue":"8070","key":"10.1016\/j.mmr.2026.100047_bib139","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41586-025-08997-x","article-title":"Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity","volume":"643","author":"Faust Akl","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2020.02.010","article-title":"An inbred ecosystem that supports medulloblastoma","volume":"52","author":"de Pablos-Aragoneses","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib141","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cell.2019.12.024","article-title":"Astrocytic trans-differentiation completes a multicellular paracrine feedback loop required for medulloblastoma tumor growth","volume":"180","author":"Yao","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib142","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1158\/2159-8290.CD-24-0134","article-title":"Timp1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells","volume":"15","author":"Priego","year":"2025","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib143","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41556-023-01241-6","article-title":"Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis","volume":"25","author":"Qu","year":"2023","journal-title":"Nat Cell Biol"},{"issue":"16","key":"10.1016\/j.mmr.2026.100047_bib144","doi-asserted-by":"crossref","first-page":"9028","DOI":"10.3390\/ijms22169028","article-title":"Effects on metabolism in astrocytes caused by cGAMP, which imitates the initial stage of brain metastasis","volume":"22","author":"Okawa","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib145","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.devcel.2024.09.003","article-title":"An ILK\/STAT3 pathway controls glioblastoma stem cell plasticity","volume":"59","author":"Loftus","year":"2024","journal-title":"Dev Cell"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib146","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","volume":"26","author":"Yuzhalin","year":"2024","journal-title":"Nat Cell Biol"},{"issue":"26","key":"10.1016\/j.mmr.2026.100047_bib147","article-title":"Brain metastasis from EGFR-mutated non-small cell lung cancer: secretion of IL11 from astrocytes up-regulates PDL1 and promotes immune escape","volume":"11","author":"Tang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib148","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-023-01518-1","article-title":"Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging treatment modalities","volume":"16","author":"Zhou","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib149","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1101","article-title":"Single-cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases","volume":"12","author":"Sun","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib151","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib152","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2021.12.043","article-title":"Cellular architecture of human brain metastases","volume":"185","author":"Gonzalez","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib153","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41698-023-00471-z","article-title":"Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases","volume":"7","author":"In","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib154","article-title":"The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/2326-6066.CIR-22-0098","article-title":"The conventional dendritic cell 1 subset primes CD8+ T cells and traffics tumor antigen to drive antitumor immunity in the brain","volume":"11","author":"Bowman-Kirigin","year":"2023","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib156","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/neuonc\/noac138","article-title":"Dysfunctional dendritic cells limit antigen-specific T cell response in glioma","volume":"25","author":"Friedrich","year":"2023","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib157","article-title":"Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells","volume":"5","author":"Sprooten","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.mmr.2026.100047_bib158","article-title":"Glioblastoma-derived exosomes promote lipid accumulation and induce ferroptosis in dendritic cells via the NRF2\/GPX4 pathway","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib159","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002181","article-title":"Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma","volume":"9","author":"Simonds","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib160","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s13046-022-02552-6","article-title":"Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed glioblastoma patients: Safety and efficacy assessment","volume":"41","author":"Bota","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib161","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","article-title":"Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial","volume":"9","author":"Liau","year":"2023","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib162","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1038\/s41467-024-48073-y","article-title":"TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase \u2161 trial","volume":"15","author":"Everson","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib163","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41551-024-01194-7","article-title":"Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells","volume":"8","author":"Lee","year":"2024","journal-title":"Nat Biomed Eng"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib164","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/neuonc\/noae149","article-title":"Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma","volume":"26","author":"Montoya","year":"2024","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib165","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor-antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib166","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/2326-6066.CIR-23-0721","article-title":"Machine learning-directed conversion of glioblastoma cells to dendritic cell-like antigen-presenting cells as cancer immunotherapy","volume":"12","author":"Liu","year":"2024","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406839","article-title":"Tumor-associated macrophages nano-reprogrammers induce \u201cgear effect\u201d to empower glioblastoma immunotherapy","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.mmr.2026.100047_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113684","article-title":"Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L\/Flt3L mRNA-mediated dendritic cell activation","volume":"382","author":"Hou","year":"2025","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib169","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41598-024-84284-5","article-title":"Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma","volume":"15","author":"L\u00fcck","year":"2025","journal-title":"Sci Rep"},{"issue":"36","key":"10.1016\/j.mmr.2026.100047_bib170","doi-asserted-by":"crossref","DOI":"10.4028\/b-fVvR5S","article-title":"Dual adjuvant-loaded peptide antigen self-assembly potentiates dendritic cell-mediated tumor immunotherapy","volume":"11","author":"Kim","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"6731","key":"10.1016\/j.mmr.2026.100047_bib171","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm5214","article-title":"Distinct myeloid-derived suppressor cell populations in human glioblastoma","volume":"387","author":"Jackson","year":"2025","journal-title":"Science"},{"issue":"8060","key":"10.1016\/j.mmr.2026.100047_bib172","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","article-title":"Programs, origins and immunomodulatory functions of myeloid cells in glioma","volume":"640","author":"Miller","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112197","article-title":"Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma","volume":"42","author":"Rajendran","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib174","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2024.05.001","article-title":"Distinct roles of TREM2 in central nervous system cancers and peripheral cancers","volume":"42","author":"Zhong","year":"2024","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib175","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade3559","article-title":"Trem2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Sci Adv"},{"issue":"22","key":"10.1016\/j.mmr.2026.100047_bib176","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163802","article-title":"A paracrine circuit of IL-1\u03b2\/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression","volume":"133","author":"Chen","year":"2023","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib177","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","article-title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","volume":"41","author":"Kilian","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib178","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cell.2020.09.064","article-title":"CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10","volume":"183","author":"Guldner","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib179","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/SLA.0000000000006428","article-title":"Infiltration of common myeloid progenitor (CMP) cells is associated with less aggressive tumor biology, lower risk of brain metastasis, better response to immunotherapy, and higher patient survival in breast cancer","volume":"280","author":"Oshi","year":"2024","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib181","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/neuonc\/noad214","article-title":"TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas","volume":"26","author":"Zheng","year":"2024","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112891","article-title":"Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment","volume":"42","author":"Canella","year":"2023","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib183","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mmr.2026.100047_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.740827","article-title":"Myeloid-derived suppressor cells: a multifaceted accomplice in tumor progression","volume":"9","author":"Cheng","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib185","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1158\/1078-0432.CCR-24-1056","article-title":"Mutant IDH modulates suppressive myeloid populations in malignant glioma","volume":"30","author":"Grewal","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mmr.2026.100047_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112922","article-title":"Immunosuppressive MDSC and Treg signatures predict prognosis and therapeutic response in glioma","volume":"141","author":"Yin","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib187","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004935","article-title":"Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry","volume":"10","author":"Nguyen","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"22","key":"10.1016\/j.mmr.2026.100047_bib188","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1158\/0008-5472.CAN-21-3840","article-title":"Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets","volume":"82","author":"Bayik","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib189","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1186\/s12885-024-12803-8","article-title":"VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells","volume":"24","author":"Tian","year":"2024","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib190","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-21-2347","article-title":"Notch-induced MDSC recruitment after oHSV virotherapy in CNS cancer models modulates antitumor immunotherapy","volume":"28","author":"Otani","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib191","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.ymthe.2021.06.023","article-title":"Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells","volume":"29","author":"Qiu","year":"2021","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib192","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.apsb.2023.09.005","article-title":"ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"23","key":"10.1016\/j.mmr.2026.100047_bib193","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1158\/1078-0432.CCR-21-1392","article-title":"Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma","volume":"27","author":"Zhai","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib194","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00262-023-03395-6","article-title":"LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells","volume":"72","author":"Wu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","article-title":"Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma","volume":"12","author":"Agliardi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.mmr.2026.100047_bib196","article-title":"Targeting myeloid-derived suppressor cells in tumor immunotherapy: current, future and beyond","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib197","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12974-020-01797-2","article-title":"Glioblastoma hijacks microglial gene expression to support tumor growth","volume":"17","author":"Maas","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib198","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-024-06903-3","article-title":"ID2-ETS2 axis regulates the transcriptional acquisition of pro-tumoral microglia phenotype in glioma","volume":"15","author":"V\u00e1zquez-Cabrera","year":"2024","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib199","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s44319-024-00117-6","article-title":"SorLA restricts TNF-\u03b1 release from microglia to shape a glioma-supportive brain microenvironment","volume":"25","author":"Kaminska","year":"2024","journal-title":"EMBO Rep"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib200","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1158\/2159-8290.CD-22-0455","article-title":"Targeting microglial metabolic rewiring synergizes with immune-checkpoint blockade therapy for glioblastoma","volume":"13","author":"Ye","year":"2023","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-024-01321-8","article-title":"Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts","volume":"16","author":"Yabo","year":"2024","journal-title":"Genome Med"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib202","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/s41556-023-01273-y","article-title":"Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis","volume":"25","author":"Evans","year":"2023","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40291-020-00469-4","article-title":"Deciphering the roles of IFITM1 in tumors","volume":"24","author":"Liang","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib204","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111112","article-title":"Immune surveillance of brain metastatic cancer cells is mediated by IFITM1","volume":"42","author":"She","year":"2023","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib205","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s43018-025-00985-4","article-title":"Glioblastoma shift from bulk to infiltrative growth is guided by plexin-B2-mediated microglia alignment in invasive niches","volume":"6","author":"Kang","year":"2025","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib206","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccell.2025.01.008","article-title":"Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases","volume":"43","author":"Rodriguez-Baena","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib207","article-title":"Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib208","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00262-020-02569-w","article-title":"Blockade of CD73 delays glioblastoma growth by modulating the immune environment","volume":"69","author":"Azambuja","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib209","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/s41401-025-01585-9","article-title":"CD73 inhibitor AB680 suppresses glioblastoma in mice by inhibiting purine metabolism and promoting P2RY12+ microglia transformation","volume":"46","author":"Gao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib210","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.ccell.2025.09.002","article-title":"Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib211","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib212","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-22-0507","article-title":"\u03b22-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib213","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.7150\/thno.93473","article-title":"The CEBPB+ glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth","volume":"14","author":"Yang","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib214","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48116-2","article-title":"Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma","volume":"13","author":"Batchu","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib215","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-022-34001-5","article-title":"Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"issue":"771","key":"10.1016\/j.mmr.2026.100047_bib216","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk1168","article-title":"Protumoral lipid droplet-loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted","volume":"16","author":"Governa","year":"2024","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib217","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1002\/tox.24259","article-title":"PTPN7 mediates macrophage-polarization and determines immunotherapy in gliomas: a single-cell sequencing analysis","volume":"39","author":"Ji","year":"2024","journal-title":"Environ Toxicol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib218","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/neuonc\/noaf208","article-title":"SPP1+ macrophages polarized by lactate confer the progression of hypoxic adaptive tumor cells in brain","volume":"28","author":"Zhang","year":"2026","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib219","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002451","article-title":"MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas","volume":"9","author":"Wang","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167449","article-title":"Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM","volume":"1870","author":"Ma","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib221","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib222","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/s41467-021-26940-2","article-title":"Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma","volume":"12","author":"Lee","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib223","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-022-02291-8","article-title":"Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization","volume":"41","author":"Li","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"22","key":"10.1016\/j.mmr.2026.100047_bib224","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-23-0576","article-title":"Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia\/macrophages by treatment with GW2580","volume":"29","author":"Fermi","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.mmr.2026.100047_bib225","first-page":"25","article-title":"Combining anti-miR-25 and cGAMP Nano complexes enhances immune responses via M2 macrophage reprogramming","author":"Petrovic","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib226","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14791","article-title":"Targeting MS4A4A: a novel pathway to improve immunotherapy responses in glioblastoma","volume":"30","author":"Shao","year":"2024","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib228","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.immuni.2024.09.003","article-title":"T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels","volume":"57","author":"Messmer","year":"2024","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib229","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00262-020-02836-w","article-title":"Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values","volume":"70","author":"Kim","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"7854","key":"10.1016\/j.mmr.2026.100047_bib230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","article-title":"A vaccine targeting mutant IDH1 in newly diagnosed glioma","volume":"592","author":"Platten","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib231","article-title":"Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases","volume":"3","author":"Sudmeier","year":"2022","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib232","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1038\/s41591-024-03152-x","article-title":"Cranioencephalic functional lymphoid units in glioblastoma","volume":"30","author":"Dobersalske","year":"2024","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib233","doi-asserted-by":"crossref","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","article-title":"Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking","volume":"115","author":"Taggart","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"10.1016\/j.mmr.2026.100047_bib234","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206208119","article-title":"The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the Th17 lineage in humans","volume":"119","author":"Mitsdoerffer","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib235","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s43018-023-00566-3","article-title":"Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation","volume":"4","author":"Wischnewski","year":"2023","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib236","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1215\/15228517-2006-006","article-title":"An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme1","volume":"8","author":"El Andaloussi","year":"2006","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib237","article-title":"Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS","author":"Jansen","year":"2023","journal-title":"Res Sq [Preprint]"},{"issue":"691","key":"10.1016\/j.mmr.2026.100047_bib238","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1016","article-title":"Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer","volume":"15","author":"Naulaerts","year":"2023","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib239","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-23-0913","article-title":"Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population","volume":"14","author":"Wang","year":"2024","journal-title":"Cancer Discov"},{"issue":"17","key":"10.1016\/j.mmr.2026.100047_bib240","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib241","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","article-title":"Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate","volume":"24","author":"Bunse","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib242","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib243","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","article-title":"The multilayered transcriptional architecture of glioblastoma ecosystems","volume":"57","author":"Nomura","year":"2025","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib244","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006243","article-title":"Heterogeneity of tumor immune microenvironment of EGFR\/ALK-positive tumors versus EGFR\/ALK-negative tumors in resected brain metastases from lung adenocarcinoma","volume":"11","author":"Xiao","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib245","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: current state, challenges, and future perspectives","volume":"21","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib246","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41577-025-01227-5","article-title":"The promise of immunotherapy for central nervous system tumours","volume":"26","author":"Mahdi","year":"2026","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib247","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib248","first-page":"674","article-title":"Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase \u2160 cohorts of checkmate 143. Neuro Oncol","volume":"20","author":"Omuro","year":"2018"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib249","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1470-2045(24)00643-0","article-title":"Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial","volume":"26","author":"Xu","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib251","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/1078-0432.CCR-15-1535","article-title":"Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas","volume":"23","author":"Kim","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib252","article-title":"TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM","volume":"7","author":"Hung","year":"2018","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib253","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/ijc.31661","article-title":"Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma","volume":"143","author":"Harris-Bookman","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mmr.2026.100047_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101007","article-title":"B7-H4 reduces the infiltration of CD8+ T cells and induces their anti-tumor dysfunction in gliomas","volume":"54","author":"Qi","year":"2024","journal-title":"Neoplasia"},{"issue":"95","key":"10.1016\/j.mmr.2026.100047_bib255","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj7970","article-title":"The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance","volume":"9","author":"Kilian","year":"2024","journal-title":"Sci Immunol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib256","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41423-024-01202-5","article-title":"Targeting the glucocorticoid receptor-CCR8 axis mediated bone marrow T cell sequestration enhances infiltration of anti-tumor T cells in intracranial cancers","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib257","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009486","article-title":"EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses","volume":"12","author":"Lertsumitkul","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"44","key":"10.1016\/j.mmr.2026.100047_bib258","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407235","article-title":"Open-source throttling of CD8+ T cells in brain with low-intensity focused ultrasound-guided sequential delivery of CXCL10, IL-2, and aPD-L1 for glioblastoma immunotherapy","volume":"36","author":"Dong","year":"2024","journal-title":"Adv Mater"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib259","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s43018-023-00600-4","article-title":"CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2DL-NKG2DL axis","volume":"4","author":"Lerner","year":"2023","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib260","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mt.2012.210","article-title":"T cells redirected to EphA2 for the immunotherapy of glioblastoma","volume":"21","author":"Chow","year":"2013","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib261","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","article-title":"CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib262","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.mmr.2026.100047_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2024.101874","article-title":"B cell clonality in cancer","volume":"72","author":"Bryushkova","year":"2024","journal-title":"Semin Immunol"},{"issue":"6695","key":"10.1016\/j.mmr.2026.100047_bib264","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.adp1865","article-title":"B cell trajectories influence cancer outcomes","volume":"384","author":"Tellier","year":"2024","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib265","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.cell.2022.06.007","article-title":"Dissecting the treatment-naive ecosystem of human melanoma brain metastasis","volume":"185","author":"Biermann","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.mmr.2026.100047_bib266","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295218","article-title":"Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma","volume":"14","author":"Hou","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib267","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2022.09.022","article-title":"Human natural killer cells: form, function, and development","volume":"151","author":"Mace","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"3b","key":"10.1016\/j.mmr.2026.100047_bib268","first-page":"1861","article-title":"Autologous natural killer cell therapy for human recurrent malignant glioma","volume":"24","author":"Ishikawa","year":"2004","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib269","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41698-023-00356-1","article-title":"Advances in NK cell therapy for brain tumors","volume":"7","author":"Fares","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"5701","key":"10.1016\/j.mmr.2026.100047_bib270","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1126\/science.1103478","article-title":"Natural killer cell signaling pathways","volume":"306","author":"Vivier","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib271","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"1-2","key":"10.1016\/j.mmr.2026.100047_bib272","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2013.08.013","article-title":"Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level","volume":"264","author":"Kmiecik","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib273","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.3390\/cancers15245836","article-title":"Unlocking glioblastoma secrets: natural killer cell therapy against cancer stem cells","volume":"15","author":"Du","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib274","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009522","article-title":"Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases","volume":"12","author":"Fife","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011581","article-title":"NK cells link immune-checkpoint blockade immunotherapy and response in melanoma brain metastases","volume":"13","author":"Kohanbash","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib276","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115896","article-title":"Characterization of HIF-1\u03b1 knockout primary human natural killer cells including populations in allogeneic glioblastoma","volume":"25","author":"Nakazawa","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib277","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13046-023-02770-6","article-title":"CIS deletion by CRISPR\/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma","volume":"42","author":"Nakazawa","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib278","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.3390\/ijms22073489","article-title":"CRISPR-Cas9-mediated TIM3 knockout in human natural killer cells enhances growth inhibitory effects on human glioma cells","volume":"22","author":"Morimoto","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.mmr.2026.100047_bib279","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib280","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the \u03b1v integrin\/TGF-\u03b2 axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"J Clin Invest"},{"issue":"Pt 9","key":"10.1016\/j.mmr.2026.100047_bib281","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1093\/brain\/awl205","article-title":"TGF-\u03b2 and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells","volume":"129","author":"Eisele","year":"2006","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib282","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/neuonc\/now061","article-title":"IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression","volume":"18","author":"Zhang","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib283","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1038\/s41467-022-32311-2","article-title":"Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands","volume":"13","author":"Zhong","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib284","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib285","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40478-025-01984-3","article-title":"Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells","volume":"13","author":"Meehan","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib286","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.3390\/ijms22189975","article-title":"Ex vivo expanded and activated natural killer cells prolong the overall survival of mice with glioblastoma-like cell-derived tumors","volume":"22","author":"Shida","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mmr.2026.100047_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116436","article-title":"CD19 CAT-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment","volume":"174","author":"Kong","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib288","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/neuonc\/noad087","article-title":"Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma","volume":"25","author":"Burger","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib289","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1145706","article-title":"Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas","volume":"14","author":"Zuo","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib290","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/acsnano.4c11250","article-title":"Cationic magnetic nanoparticles activate natural killer cells for the treatment of glioblastoma","volume":"19","author":"Rao","year":"2025","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib291","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105857","article-title":"NKG2C+ NK cells for immunotherapy of glioblastoma multiforme","volume":"23","author":"Murad","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib292","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis","volume":"184","author":"Mathewson","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib293","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ccell.2024.07.003","article-title":"When playing the NK cell therapy card in glioblastoma, you can\u2019t beat interleukin-21","volume":"42","author":"Huntington","year":"2024","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib294","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.ccell.2024.07.007","article-title":"Interleukin-21 engineering enhances NK cell activity against glioblastoma via cebpd","volume":"42","author":"Shanley","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13046-024-03144-2","article-title":"Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma","volume":"43","author":"Chen","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.mmr.2026.100047_bib296","doi-asserted-by":"crossref","DOI":"10.3390\/cells13131155","article-title":"Suppressing PD-L1 expression via AURKA kinase inhibition enhances natural killer cell-mediated cytotoxicity against glioblastoma","volume":"13","author":"Nguyen","year":"2024","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib297","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009210","article-title":"NKG2C\/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma","volume":"12","author":"de Dios","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib298","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnci\/djad226","article-title":"Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma","volume":"116","author":"Pan","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib299","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ccell.2024.08.008","article-title":"Glioblastoma induces the recruitment and differentiation of dendritic-like \"hybrid\" neutrophils from skull bone marrow","volume":"42","author":"Lad","year":"2024","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib300","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"issue":"28","key":"10.1016\/j.mmr.2026.100047_bib301","article-title":"Inducing ectopic T cell clusters using stromal vascular fraction spheroid-based immunotherapy to enhance anti-tumor immunity","volume":"9","author":"Lee","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib302","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib303","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.immuni.2025.09.018","article-title":"Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures","volume":"58","author":"Cakmak","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib304","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/neuonc\/noae167","article-title":"Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity","volume":"27","author":"Shen","year":"2025","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib305","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib306","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","article-title":"Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib307","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-025-02007-x","article-title":"Identification and characterization of tertiary lymphoid structures in brain metastases","volume":"13","author":"Mughal","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib308","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009232","article-title":"Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis","volume":"12","author":"Zhao","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib309","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.21873\/anticanres.17184","article-title":"Tertiary lymphoid structures in brain metastases of lung cancer: prognostic significance and correlation with clinical outcomes","volume":"44","author":"Nohira","year":"2024","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib310","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","article-title":"Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis","volume":"32","author":"Lee","year":"2019","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib311","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1007\/s12035-024-03937-8","article-title":"HCMV IE1\/IE1mut therapeutic vaccine induces tumor regression via intratumoral tertiary lymphoid structure formation and peripheral immunity activation in glioblastoma multiforme","volume":"61","author":"Yang","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib312","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","article-title":"Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma","volume":"12","author":"van Hooren","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib313","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41392-025-02260-5","article-title":"De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer","volume":"10","author":"Ahmed","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib314","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009603","article-title":"Intratumoral CXCL13+CD160+CD8+ T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer","volume":"12","author":"Wang","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib315","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib316","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181517","article-title":"ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non-small cell lung cancer","volume":"135","author":"Jiao","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mmr.2026.100047_bib317","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216593","article-title":"Neovascularization directed by CAVIN1\/CCBE1\/VEGFC confers TMZ-resistance in glioblastoma","volume":"582","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib318","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/neuonc\/noad236","article-title":"Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance","volume":"26","author":"Kim","year":"2024","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib319","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41419-022-04959-7","article-title":"Paradoxical role of \u03b28 integrin on angiogenesis and vasculogenic mimicry in glioblastoma","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib320","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/neuonc\/noab022","article-title":"Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling","volume":"23","author":"Schaffenrath","year":"2021","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib321","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2020.12.019","article-title":"Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment","volume":"110","author":"Wei","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib322","first-page":"240","article-title":"Tspo deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma","volume":"22","author":"Fu","year":"2020","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib323","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","article-title":"Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib324","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj4678","article-title":"An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma","volume":"10","author":"Yang","year":"2024","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib325","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/neuonc\/noae094","article-title":"Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis","volume":"26","author":"Roesler","year":"2024","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib326","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.immuni.2024.09.003","article-title":"T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels","volume":"57","author":"Messmer","year":"2024","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib327","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/neuonc\/noab181","article-title":"ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma","volume":"24","author":"Huang","year":"2022","journal-title":"Neuro Oncol"},{"issue":"31","key":"10.1016\/j.mmr.2026.100047_bib328","article-title":"Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model","volume":"9","author":"Ngo","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.mmr.2026.100047_bib329","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115702","article-title":"vitro models of the interplay between glioblastoma and blood-brain barrier for stratifying drug efficacy","volume":"227","author":"Ferreira","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib330","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.32902","article-title":"Cerebrovascular inflammation promotes the formation of brain metastases","volume":"147","author":"Sikpa","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib331","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41419-023-06416-5","article-title":"IFTM3 promotes glioblastoma stem cell-mediated angiogenesis via regulating JAK\/STAT3\/bFGF signaling pathway","volume":"15","author":"Xiong","year":"2024","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib332","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112127","article-title":"Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma","volume":"42","author":"Pang","year":"2023","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib333","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cels.2021.01.002","article-title":"TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progression","volume":"12","author":"K\u00e4lin","year":"2021","journal-title":"Cell Syst"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib334","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.stem.2022.09.009","article-title":"Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib335","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41419-024-06603-y","article-title":"DMRTA2 supports glioma stem-cell mediated neovascularization in glioblastoma","volume":"15","author":"Maleszewska","year":"2024","journal-title":"Cell Death Dis"},{"issue":"7792","key":"10.1016\/j.mmr.2026.100047_bib336","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib337","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1021\/acsnano.4c15860","article-title":"Targeted modulation of the meningeal lymphatic reverse pathway for immunotherapy of breast cancer brain metastases","volume":"19","author":"Dai","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib338","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12987-024-00590-0","article-title":"Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro","volume":"21","author":"Digiovanni","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib339","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.devcel.2021.09.018","article-title":"Breaking down barriers: Tumors make a leaky brain","volume":"56","author":"Benmimoun","year":"2021","journal-title":"Dev Cell"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib340","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.devcel.2021.08.010","article-title":"Tumor-induced disruption of the blood-brain barrier promotes host death","volume":"56","author":"Kim","year":"2021","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib341","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70038","article-title":"Breast cancer-derived extracellular vesicles modulate the cytoplasmic and cytoskeletal dynamics of blood-brain barrier endothelial cells","volume":"14","author":"Busatto","year":"2025","journal-title":"J Extracell Vesicles"},{"issue":"13","key":"10.1016\/j.mmr.2026.100047_bib342","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.3390\/ijms22137057","article-title":"Behind brain metastases formation: cellular and molecular alterations and blood-brain barrier disruption","volume":"22","author":"Godinho-Pereira","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib343","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/neuonc\/noae169","article-title":"ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in human epidermal growth factor receptor 2-positive breast cancer","volume":"27","author":"Santos","year":"2025","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib344","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3390\/ijms23031900","article-title":"Insights into the steps of breast cancer-brain metastases development: tumor cell interactions with the blood-brain barrier","volume":"23","author":"Hamester","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib345","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00018-024-05217-z","article-title":"Vascular mimicry as a facilitator of melanoma brain metastasis","volume":"81","author":"Provance","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib346","first-page":"834","article-title":"ATM activation is key in vasculogenic mimicry formation by glioma stem-like cells","volume":"37","author":"Xie","year":"2024","journal-title":"Biomed Environ Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib347","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10565-024-09890-5","article-title":"HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells","volume":"40","author":"Wang","year":"2024","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib348","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s10565-023-09836-3","article-title":"SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1\/DKK1 pathway","volume":"39","author":"Cao","year":"2023","journal-title":"Cell Biol Toxicol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib349","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neo.2018.08.011","article-title":"CXCR2-expressing tumor cells drive vascular mimicry in antiangiogenic therapy-resistant glioblastoma","volume":"20","author":"Angara","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.mmr.2026.100047_bib350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116458","article-title":"Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression","volume":"227","author":"Luo","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"10.1016\/j.mmr.2026.100047_bib351","doi-asserted-by":"crossref","first-page":"11789","DOI":"10.3390\/ijms252111789","article-title":"Ruta graveolens, but not rutin, inhibits survival, migration, invasion, and vasculogenic mimicry of glioblastoma cells","volume":"25","author":"Camerino","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib352","article-title":"Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling","volume":"5","author":"Cheng","year":"2024","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib353","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1158\/2326-6066.CIR-22-0872","article-title":"Glioblastoma vascular plasticity limits effector T-cell infiltration and is blocked by CAMP activation","volume":"11","author":"Qin","year":"2023","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib354","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr1481","article-title":"Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM","volume":"11","author":"Jimenez-Macias","year":"2025","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib355","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ijrobp.2024.02.007","article-title":"Microbeam radiation therapy opens a several days\u2019 vessel permeability window for small molecules in brain tumor vessels","volume":"119","author":"Potez","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib356","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat Commun"},{"issue":"728","key":"10.1016\/j.mmr.2026.100047_bib357","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib358","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","article-title":"Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy","volume":"15","author":"Jiang","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib359","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1078-0432.CCR-20-2400","article-title":"Modification of extracellular matrix enhances oncolytic adenovirus immunotherapy in glioblastoma","volume":"27","author":"Kiyokawa","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib360","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41556-024-01532-6","article-title":"Differential stiffness between brain vasculature and parenchyma promotes metastatic infiltration through vessel co-option","volume":"26","author":"Uroz","year":"2024","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib361","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1073\/pnas.1913511116","article-title":"How tissue fluidity influences brain tumor progression","volume":"117","author":"Streitberger KJ","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib362","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3892\/or.2024.8835","article-title":"Compression force promotes glioblastoma progression through the Piezo1\u2011GDF15\u2011CTLA4 axis","volume":"53","author":"Kim","year":"2025","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib363","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuron.2022.10.007","article-title":"Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity","volume":"111","author":"Chen","year":"2023","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib364","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166513","article-title":"Substrate viscosity impairs temozolomide-mediated inhibition of glioblastoma cells' growth","volume":"1868","author":"Cie\u015bluk","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"20","key":"10.1016\/j.mmr.2026.100047_bib365","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322688121","article-title":"Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies","volume":"121","author":"Goyette","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib366","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-19-2961","article-title":"Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches","volume":"80","author":"Hebert","year":"2020","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib367","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41698-025-01100-7","article-title":"ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas","volume":"9","author":"Wei","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib368","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13265","article-title":"Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination","volume":"34","author":"Vymola","year":"2024","journal-title":"Brain Pathol"},{"issue":"45","key":"10.1016\/j.mmr.2026.100047_bib369","article-title":"Loss of fibronectin fiber tension in glioblastoma is associated with microvascular proliferations and immune cell infiltration","volume":"12","author":"Crestani","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib370","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau4245","article-title":"Identification of variable lymphocyte receptors that can target therapeutics to pathologically exposed brain extracellular matrix","volume":"5","author":"Umlauf","year":"2019","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib371","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2356942","article-title":"HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis","volume":"13","author":"You","year":"2024","journal-title":"OncoImmunology"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib372","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.pathol.2023.05.003","article-title":"Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours","volume":"55","author":"Zuba\u013e","year":"2023","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib373","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib374","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1605","article-title":"Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib375","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41598-025-85531-z","article-title":"Single-cell profiling transcriptomic reveals cellular heterogeneity and cellular crosstalk in breast cancer lymphatic node, bone, and brain metastases","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib376","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s42003-023-05124-2","article-title":"Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment","volume":"6","author":"Song","year":"2023","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib377","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7150\/jca.80115","article-title":"Different expression and clinical implications of cancer-associated fibroblast (CAF) markers in brain metastases","volume":"14","author":"Akanda","year":"2023","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib378","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12885-023-10957-5","article-title":"Analysis of stromal PDGFR-\u03b2 and \u03b1-SMA expression and their clinical relevance in brain metastases of breast cancer patients","volume":"23","author":"Akanda","year":"2023","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib379","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147087","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects","volume":"133","author":"Jain","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib380","doi-asserted-by":"crossref","first-page":"C252","DOI":"10.1152\/ajpcell.00234.2023","article-title":"Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization","volume":"326","author":"Zhang","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib381","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113463","article-title":"Brain metastasis-associated fibroblasts secrete fucosylated PVR\/CD155 that induces breast cancer invasion","volume":"42","author":"Adhikari","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.mmr.2026.100047_bib382","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.111016","article-title":"Cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma","volume":"115","author":"Zhang","year":"2024","journal-title":"Cell Signal"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib383","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176613","article-title":"Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas","volume":"134","author":"Tripathi","year":"2024","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib384","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib386","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41577-022-00796-z","article-title":"TGF\u03b2 control of immune responses in cancer: a holistic immuno-oncology perspective","volume":"23","author":"Nixon","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib387","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/neuonc\/noab212","article-title":"TGF-\u03b2 promotes microtube formation in glioblastoma through thrombospondin 1","volume":"24","author":"Joseph","year":"2022","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib388","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006164","article-title":"PKR induces TGF-\u03b2 and limits oncolytic immune therapy","volume":"11","author":"Hong","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"21","key":"10.1016\/j.mmr.2026.100047_bib389","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167049","article-title":"The semaphorin 3A\/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-\u03b2 signaling","volume":"8","author":"Jeon","year":"2023","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib390","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.7150\/thno.69605","article-title":"TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin \u03b1v\u03b25-Src-Stat3 signaling","volume":"12","author":"Peng","year":"2022","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib391","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib392","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/modpathol.2011.5","article-title":"IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence","volume":"24","author":"Itakura","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib393","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1038\/s41467-020-18569-4","article-title":"Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression","volume":"11","author":"De Boeck","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib394","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12929-025-01126-w","article-title":"IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment","volume":"32","author":"Lee","year":"2025","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib395","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","article-title":"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib396","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006239","article-title":"IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM","volume":"11","author":"Zannikou","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib397","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-024-06784-6","article-title":"CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib398","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41467-022-29647-0","article-title":"Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib399","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2338965","article-title":"CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy","volume":"13","author":"Pant","year":"2024","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib400","article-title":"Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib401","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/neuonc\/noae126","article-title":"IL-13R\u03b12\/TGF-\u03b2 bispecific CAR-T cells counter TGF-\u03b2-mediated immune suppression and potentiate anti-tumor responses in glioblastoma","volume":"26","author":"Hou","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib402","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib403","article-title":"CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines","volume":"6","author":"Look","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib404","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41392-025-02514-2","article-title":"Lipocalin-2 drives brain metastatic progression through reciprocal tumor-microenvironment interactions in lung cancer","volume":"10","author":"Zhu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.mmr.2026.100047_bib405","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cytogfr.2024.02.003","article-title":"Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy","volume":"76","author":"Xu","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib406","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.7150\/ijbs.91112","article-title":"The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury","volume":"20","author":"Ning","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.mmr.2026.100047_bib407","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115456","article-title":"The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: from experimental study to clinical application","volume":"167","author":"Ning","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib408","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","article-title":"Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: targeting SLC25A1 to overcome immune resistance","volume":"37","author":"Zhang","year":"2025","journal-title":"Chin J Cancer Res"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib409","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00018-022-04453-5","article-title":"Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtdna damage","volume":"79","author":"Deng","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib410","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115343","article-title":"Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis","volume":"14","author":"Guyon","year":"2022","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib411","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","article-title":"DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib412","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/neuonc\/noac231","article-title":"Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression","volume":"25","author":"Yang","year":"2023","journal-title":"Neuro Oncol"},{"issue":"8084","key":"10.1016\/j.mmr.2026.100047_bib413","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-025-09460-7","article-title":"Rewiring of cortical glucose metabolism fuels human brain cancer growth","volume":"646","author":"Scott","year":"2025","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib414","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.70103","article-title":"The spatial distribution of brain metastasis is determined by the heterogeneity of the brain microenvironment","volume":"45","author":"Bao","year":"2024","journal-title":"Hum Brain Mapp"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib415","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","article-title":"Natural coevolution of tumor and immunoenvironment in glioblastoma","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.mmr.2026.100047_bib416","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216801","article-title":"Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages","volume":"590","author":"Dong","year":"2024","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib417","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/15548627.2020.1731266","article-title":"Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5","volume":"17","author":"Feng","year":"2021","journal-title":"Autophagy"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib418","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190470","article-title":"HIF-1 promotes murine breast cancer brain metastasis by increasing production of integrin \u03b23-containing extracellular vesicles","volume":"135","author":"Yang","year":"2025","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib419","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.00124.2024","article-title":"Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner","volume":"327","author":"Li","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib420","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","article-title":"Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma","volume":"40","author":"Ravi","year":"2022","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib421","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41590-020-00860-7","article-title":"Tumor hypoxia represses \u03b3\u03b4 T cell-mediated antitumor immunity against brain tumors","volume":"22","author":"Park","year":"2021","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib422","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177141","article-title":"Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment","volume":"9","author":"Hatae","year":"2024","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib423","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib424","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2023.11.013","article-title":"Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth","volume":"36","author":"Rashidi","year":"2024","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib425","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1002\/cam4.5857","article-title":"A pilot study: metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients","volume":"12","author":"Muller Bark","year":"2023","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib426","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112790","article-title":"SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells","volume":"42","author":"Geng","year":"2023","journal-title":"Cell Rep"},{"issue":"20","key":"10.1016\/j.mmr.2026.100047_bib427","article-title":"PERK-mediated cholesterol excretion from IDH mutant glioma determines anti-tumoral polarization of microglia","volume":"10","author":"Wang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib428","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/0008-5472.CAN-19-0638","article-title":"Localized metabolomic gradients in patient-derived xenograft models of glioblastoma","volume":"80","author":"Randall","year":"2020","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib429","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1158\/0008-5472.CAN-20-0137","article-title":"Metabolite imaging at the margin: visualizing metabolic tumor gradients using mass spectrometry","volume":"80","author":"Tan","year":"2020","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib430","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.cell.2024.07.030","article-title":"Macrophage-mediated myelin recycling fuels brain cancer malignancy","volume":"187","author":"Kloosterman","year":"2024","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib431","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009492","article-title":"ALOX5 contributes to glioma progression by promoting 5-hete-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia\/macrophages","volume":"12","author":"Chen","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib432","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190471","article-title":"Lipid peroxidation and immune activation: TRAF3\u2019s double-edged strategy against glioblastoma","volume":"135","author":"Chia","year":"2025","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib433","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.mmr.2026.100047_bib434","article-title":"Immunostimulatory hydrogel with synergistic blockage of glutamine metabolism and chemodynamic therapy for postoperative management of glioblastoma","volume":"12","author":"Guo","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib435","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-19-3923","article-title":"Brain tumor stem cell dependence on glutaminase reveals a metabolic vulnerability through the amino acid deprivation response pathway","volume":"80","author":"Restall","year":"2020","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.mmr.2026.100047_bib436","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-21-3868","article-title":"Targeting BCAT1 combined with \u03b1-ketoglutarate triggers metabolic synthetic lethality in glioblastoma","volume":"82","author":"Zhang","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib437","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00018-024-05497-5","article-title":"Activated kynurenine pathway metabolism by YKL-40 establishes an inhibitory immune microenvironment and drives glioblastoma development","volume":"82","author":"Chen","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib438","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.7150\/ijbs.85672","article-title":"Branch chain amino acid metabolism promotes brain metastasis of NSCLC through emt occurrence by regulating ALKBH5 activity","volume":"20","author":"Mao","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib439","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1016\/j.ymthe.2024.05.017","article-title":"BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism","volume":"32","author":"Yang","year":"2024","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib440","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib441","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.mmr.2026.100047_bib442","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib443","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"issue":"46","key":"10.1016\/j.mmr.2026.100047_bib444","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci Adv"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib445","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib446","article-title":"Metabolism\/immunity dual-regulation thermogels potentiating immunotherapy of glioblastoma through lactate-excretion inhibition and PD-1\/PD-L1 blockade","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib447","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1038\/s41467-024-52888-0","article-title":"Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib448","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177824","article-title":"Tumor cell-derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition","volume":"135","author":"Kay","year":"2024","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib449","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib450","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib451","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00457-24","article-title":"Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma","volume":"10","author":"Li","year":"2025","journal-title":"mSystems"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib452","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/ijms26030991","article-title":"Brain tumors and beyond: multi-compartment microbiome and mycobiome analysis","volume":"26","author":"Sipos","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib453","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304403","article-title":"Discussion on the relationship between gut microbiota and glioma through Mendelian randomization test based on the brain gut axis","volume":"19","author":"Cui","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.mmr.2026.100047_bib454","article-title":"Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets","volume":"13","author":"Jiang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib455","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70068","article-title":"Metagenomics and non-targeted metabolomics reveal the role of gut microbiota and its metabolites in brain metastasis of non-small cell lung cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib456","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111874","article-title":"The bacterial microbiome modulates the initiation of brain metastasis by impacting the gut-to-brain axis","volume":"28","author":"Massara","year":"2025","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib457","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1080\/21655979.2022.2049959","article-title":"The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.mmr.2026.100047_bib458","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112881","article-title":"Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment","volume":"141","author":"Zhou","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib459","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115356","article-title":"Temporal dynamics of immune cell transcriptomics in brain metastasis progression influenced by gut microbiome dysbiosis","volume":"44","author":"Golomb","year":"2025","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib460","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1038\/s41467-025-56930-7","article-title":"Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase \u2160\/\u2161 trial","volume":"16","author":"Weathers","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib461","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12864-023-09885-2","article-title":"Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study","volume":"24","author":"Zeng","year":"2023","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib462","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/metabo12040290","article-title":"Late-stage glioma is associated with deleterious alteration of gut bacterial metabolites in mice","volume":"12","author":"Herbreteau","year":"2022","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib463","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30494","article-title":"The gut-brain-axis: a positive relationship between gut microbial dysbiosis and glioblastoma brain tumour","volume":"10","author":"Ishaq","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.mmr.2026.100047_bib464","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1404745","article-title":"Revealing the link between gut microbiota and brain tumor risk: a new perspective from mendelian randomization","volume":"14","author":"Yang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib465","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201948354","article-title":"Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice","volume":"50","author":"D'Alessandro","year":"2020","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib466","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00262-021-03080-6","article-title":"The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor","volume":"71","author":"Nie","year":"2022","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib467","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41467-024-48606-5","article-title":"Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib468","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77919-w","article-title":"Glioma and temozolomide induced alterations in gut microbiome","volume":"10","author":"Patrizz","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.mmr.2026.100047_bib469","article-title":"Combination of sodium butyrate and immunotherapy in glioma: regulation of immunologically hot and cold tumors via gut microbiota and metabolites","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib470","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113220","article-title":"Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulation","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep"},{"issue":"6478","key":"10.1016\/j.mmr.2026.100047_bib471","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib472","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.mmr.2026.100047_bib473","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1073\/pnas.1104261108","article-title":"Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells","volume":"108","author":"Svensson","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib474","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1073\/pnas.1220998110","article-title":"Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development","volume":"110","author":"Kucharzewska","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib475","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1158\/1535-7163.MCT-25-0117","article-title":"Acrolein induces the exosomal miR-30a-5p\/NCAM1 axis promoting glioma progression","volume":"24","author":"Tsai","year":"2025","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib476","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1158\/1541-7786.MCR-16-0163","article-title":"Exosomal annexin \u2161 promotes angiogenesis and breast cancer metastasis","volume":"15","author":"Maji","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.mmr.2026.100047_bib477","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2022.03.038","article-title":"Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2","volume":"345","author":"Yang","year":"2022","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib478","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mmr.2026.100047_bib479","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/neuonc\/nov244","article-title":"Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia\/macrophages in the brain","volume":"18","author":"van der Vos","year":"2016","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib481","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/neuonc\/nov170","article-title":"Glioma-derived extracellular vesicles selectively suppress immune responses","volume":"18","author":"Hellwinkel","year":"2016","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib482","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11060-024-04934-6","article-title":"Glioblastoma- derived exosomes (GBM-Exo) regulate microglial M2 polarization via the RAC1\/AKT\/NRF2 pathway","volume":"172","author":"Wu","year":"2025","journal-title":"J Neurooncol"},{"key":"10.1016\/j.mmr.2026.100047_bib483","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102454","article-title":"Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth","volume":"56","author":"Tian","year":"2022","journal-title":"Redox biology"},{"issue":"7576","key":"10.1016\/j.mmr.2026.100047_bib484","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microrna primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib485","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/ijc.29521","article-title":"Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells","volume":"137","author":"de Vrij","year":"2015","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib486","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","article-title":"Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis","volume":"21","author":"Rodrigues","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.mmr.2026.100047_bib487","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-026-00957-1","article-title":"Lactate-activated astrocytes promote NSCLC brain metastasis through extracellular vesicle-mediated miR-8085\/TRIM67\/ELK1 signaling axis","author":"Peng","year":"2026","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib488","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/cgt.2016.78","article-title":"Extracellular vesicle-mediated suicide mRNA\/protein delivery inhibits glioblastoma tumor growth in vivo","volume":"24","author":"Erkan","year":"2017","journal-title":"Cancer gene therapy"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib489","article-title":"Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity","volume":"2","author":"Munoz","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib490","article-title":"Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma","volume":"5","author":"Yang","year":"2024","journal-title":"Exploration (Beijing)"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib491","doi-asserted-by":"crossref","first-page":"17309","DOI":"10.1021\/acsnano.4c14573","article-title":"Glioblastoma cell derived exosomes as a potent vaccine platform targeting primary brain cancers and brain metastases","volume":"19","author":"Zou","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mmr.2026.100047_bib492","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jconrel.2023.10.007","article-title":"Engineering car-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy","volume":"363","author":"Tao","year":"2023","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib493","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1109\/TUFFC.2023.3320034","article-title":"Longitudinal 3D visualization of microvascular disruption and perfusion changes in mice during the evolution of glioblastoma using super-resolution ultrasound","volume":"70","author":"McCall","year":"2023","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib494","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ultrasmedbio.2025.02.007","article-title":"An early progression biomarker in glioblastoma: microcirculatory heterogeneity on ultrasound localization microscopy","volume":"51","author":"Hu","year":"2025","journal-title":"Ultrasound Med Biol"},{"issue":"49","key":"10.1016\/j.mmr.2026.100047_bib495","doi-asserted-by":"crossref","first-page":"15904","DOI":"10.1021\/acs.nanolett.4c04986","article-title":"Stimulated emission depletion imaging reveals mitochondrial phenotypic heterogeneity under apoptosis stimuli across living glioma models","volume":"24","author":"Gao","year":"2024","journal-title":"Nano Lett"},{"issue":"21","key":"10.1016\/j.mmr.2026.100047_bib496","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1039\/D1NR02128A","article-title":"Super resolution microscopy reveals DHA-dependent alterations in glioblastoma membrane remodelling and cell migration","volume":"13","author":"Xu","year":"2021","journal-title":"Nanoscale"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib497","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1039\/D2TB00322H","article-title":"Comprehensive exploration of long-wave emission carbon dots for brain tumor visualization","volume":"10","author":"Zhao","year":"2022","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.mmr.2026.100047_bib498","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113544","article-title":"Dual-targeted transferrin and AS1411 aptamer conjugated micelles for improved therapeutic efficacy and imaging of brain cancer","volume":"231","author":"Chauhan","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"27","key":"10.1016\/j.mmr.2026.100047_bib499","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301000","article-title":"A ratiometric SERS probe for imaging the macrophage phenotypes in live mice with epilepsy and brain tumor","volume":"12","author":"Duan","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.mmr.2026.100047_bib500","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114536","article-title":"Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors","volume":"190","author":"Zhang","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib501","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1021\/acsami.0c22489","article-title":"Long-term near-infrared signal tracking of the therapeutic changes of glioblastoma cells in brain tissue with ultrasound-guided persistent luminescent nanocomposites","volume":"13","author":"Cheng","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib502","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-022-01525-9","article-title":"Liquid biopsy: exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer","volume":"21","author":"Preethi","year":"2022","journal-title":"Mol Cancer"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib503","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/neuonc\/noae032","article-title":"Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review","volume":"26","author":"Nayak","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib504","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1038\/s41467-023-41434-z","article-title":"Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas","volume":"14","author":"Herrgott","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib505","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-022-01577-x","article-title":"Liquid biopsies to occult brain metastasis","volume":"21","author":"Rehman","year":"2022","journal-title":"Mol Cancer"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib506","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s12276-020-00501-x","article-title":"Brain tumor diagnostic model and dietary effect based on extracellular vesicle microbiome data in serum","volume":"52","author":"Yang","year":"2020","journal-title":"Exp Mol Med"},{"issue":"20","key":"10.1016\/j.mmr.2026.100047_bib507","doi-asserted-by":"crossref","first-page":"19832","DOI":"10.1021\/acsnano.3c04118","article-title":"Self-functionalized superlattice nanosensor enables glioblastoma diagnosis using liquid biopsy","volume":"17","author":"Premachandran","year":"2023","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib508","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/cac2.12410","article-title":"Integrated circulating tumor DNA and T cell repertoire predict radiotherapeutic response and outcome in non-small cell lung cancer patients with brain metastasis","volume":"43","author":"Peng","year":"2023","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib509","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7150\/thno.65597","article-title":"Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA","volume":"12","author":"Pacia","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib510","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","article-title":"Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target","volume":"13","author":"Abdelfattah","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.mmr.2026.100047_bib511","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112676","article-title":"Single-cell RNA-sequencing analysis reveals \u03b1-syn induced astrocyte-neuron crosstalk-mediated neurotoxicity","volume":"139","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib512","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41467-023-36707-6","article-title":"Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas","volume":"14","author":"Ren","year":"2023","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib513","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/s41416-024-02882-6","article-title":"Spatial analysis by current multiplexed imaging technologies for the molecular characterisation of cancer tissues","volume":"131","author":"Semba","year":"2024","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib514","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s44303-024-00025-3","article-title":"Mass spectrometry imaging for spatially resolved multi-omics molecular mapping","volume":"2","author":"Zhang","year":"2024","journal-title":"Npj Imaging"},{"issue":"34","key":"10.1016\/j.mmr.2026.100047_bib515","doi-asserted-by":"crossref","first-page":"44518","DOI":"10.1021\/acsami.4c09394","article-title":"Albumin-based microneedles for spatiotemporal delivery of temozolomide and niclosamide to resistant glioblastoma","volume":"16","author":"Yang","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib516","article-title":"Spatiotemporal insights into glioma oncostream dynamics: unraveling formation, stability, and disassembly pathways","volume":"11","author":"Faisal","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib517","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41590-022-01215-0","article-title":"Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression","volume":"23","author":"Yeo","year":"2022","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib518","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2015.07.013","article-title":"Spatiotemporal evolution of the primary glioblastoma genome","volume":"28","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib519","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/neuonc\/noad208","article-title":"Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism","volume":"26","author":"Cosenza-Contreras","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib520","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1038\/s41467-022-31340-1","article-title":"Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression","volume":"13","author":"Comba","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib521","article-title":"Integrating metabolic RNA labeling-based time-resolved single-cell RNA sequencing with spatial transcriptomics for spatiotemporal transcriptomic analysis","volume":"9","author":"Chen","year":"2025","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib522","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2163781","article-title":"In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer","volume":"12","author":"Xu","year":"2023","journal-title":"OncoImmunology"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib523","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.neo.2021.09.001","article-title":"In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM\/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer","volume":"23","author":"Zhang","year":"2021","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib524","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1158\/1541-7786.MCR-20-0863","article-title":"Identification and characterization of cancer cells that initiate metastases to the brain and other organs","volume":"19","author":"Berghoff","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib525","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2021.07.038","article-title":"vivo imaging of the microglial landscape after whole brain radiation therapy","volume":"111","author":"Whitelaw","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib526","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","article-title":"Integrated proteogenomic characterization of glioblastoma evolution","volume":"42","author":"Kim","year":"2024","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib527","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13228","article-title":"DistSNE: distributed computing and online visualization of DNA methylation-based central nervous system tumor classification","volume":"34","author":"Schmid","year":"2024","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib528","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-025-01710-5","article-title":"Panoramic spatial enhanced resolution proteomics (PSERP) reveals tumor architecture and heterogeneity in gliomas","volume":"18","author":"Xu","year":"2025","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib529","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae051","article-title":"Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma","volume":"3","author":"Watanabe","year":"2024","journal-title":"PNAS Nexus"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib530","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/cns.14272","article-title":"Applications of organoid technology to brain tumors","volume":"29","author":"Wen","year":"2023","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib531","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/neuonc\/noae245","article-title":"Neuroimmune-competent human brain organoid model of diffuse midline glioma","volume":"27","author":"Sarnow","year":"2025","journal-title":"Neuro Oncol"},{"issue":"6579","key":"10.1016\/j.mmr.2026.100047_bib532","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf5546","article-title":"Amplification of human interneuron progenitors promotes brain tumors and neurological defects","volume":"375","author":"Eichm\u00fcller","year":"2022","journal-title":"Science"},{"issue":"815","key":"10.1016\/j.mmr.2026.100047_bib533","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp7047","article-title":"Human myelinated brain organoids with integrated microglia as a model for myelin repair and remyelinating therapies","volume":"17","author":"Lange","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mmr.2026.100047_bib534","first-page":"520","article-title":"A ceramic microbridge microfluidic chip to study osteogenic differentiation of mesenchymal stem cells in bioactive ceramic immune microenvironment","volume":"45","author":"Ye","year":"2025","journal-title":"Bioact Mater"},{"key":"10.1016\/j.mmr.2026.100047_bib535","article-title":"Application of microfluidic chips in the simulation of the urinary system microenvironment","volume":"19","author":"Hou","year":"2023","journal-title":"Mater Today Bio"},{"issue":"21","key":"10.1016\/j.mmr.2026.100047_bib536","article-title":"Investigating the interactions of glioma stem cells in the perivascular niche at single-cell resolution using a microfluidic tumor microenvironment model","volume":"9","author":"Adjei-Sowah","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib537","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1039\/D1LC00271F","article-title":"On-chip perivascular niche supporting stemness of patient-derived glioma cells in a serum-free, flowable culture","volume":"21","author":"Gerigk","year":"2021","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib538","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-024-03015-w","article-title":"Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET","volume":"43","author":"Xia","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib539","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/cam4.1174","article-title":"Organotypic brain explant culture as a drug evaluation system for malignant brain tumors","volume":"6","author":"Minami","year":"2017","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib540","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/neuonc\/noae195","article-title":"Potential of ex vivo organotypic slice cultures in neuro-oncology","volume":"27","author":"Steindl","year":"2025","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib541","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41592-024-02503-3","article-title":"Mapping the topography of spatial gene expression with interpretable deep learning","volume":"22","author":"Chitra","year":"2025","journal-title":"Nat Methods"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib542","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/neuonc\/noae013","article-title":"Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes","volume":"26","author":"Dankner","year":"2024","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib543","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/neuonc\/noac169","article-title":"Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions","volume":"25","author":"Buehler","year":"2023","journal-title":"Neuro Oncol"},{"issue":"20","key":"10.1016\/j.mmr.2026.100047_bib544","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/0008-5472.CAN-20-0291","article-title":"Brain metastasis cell lines panel: a public resource of organotropic cell lines","volume":"80","author":"Valiente","year":"2020","journal-title":"Cancer Res"},{"issue":"7837","key":"10.1016\/j.mmr.2026.100047_bib545","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41586-020-2969-2","article-title":"A metastasis map of human cancer cell lines","volume":"588","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib546","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13046-025-03315-9","article-title":"GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer","volume":"44","author":"Xie","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.mmr.2026.100047_bib547","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.3390\/ijms25168708","article-title":"Molecular determinants for photodynamic therapy resistance and improved photosensitizer delivery in glioma","volume":"25","author":"Aebisher","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib548","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7150\/ijbs.91295","article-title":"Radiotherapy in preclinical models of brain metastases: a review and recommendations for future studies","volume":"20","author":"Shi","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib549","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008967","article-title":"ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM","volume":"12","author":"Long","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib550","article-title":"Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma","volume":"3","author":"Dees","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib551","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ros by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib552","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/neuonc\/noaa266","article-title":"Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier","volume":"23","author":"Genovesi","year":"2021","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib553","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00401-020-02226-7","article-title":"Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology","volume":"140","author":"Golebiewska","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.mmr.2026.100047_bib554","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101051","article-title":"Probing the glioma micro-environment: analysis using biopsy in combination with ultra-fast cyclic immunolabeling","volume":"57","author":"van Solinge","year":"2024","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib555","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/adc03a","article-title":"3D bioprinting technology for modeling vascular diseases and its application","volume":"17","author":"Kim","year":"2025","journal-title":"Biofabrication"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib556","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1021\/acsbiomaterials.3c01569","article-title":"Applications of 3D bioprinting technology to brain cells and brain tumor models: special emphasis to glioblastoma","volume":"10","author":"Ozbek","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib557","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004776","article-title":"Biomaterials and 3D bioprinting strategies to model glioblastoma and the blood-brain barrier","volume":"33","author":"Tang","year":"2021","journal-title":"Adv Mater"},{"issue":"15","key":"10.1016\/j.mmr.2026.100047_bib558","article-title":"A 3D bioprinted human neurovascular unit model of glioblastoma tumor growth","volume":"13","author":"Tung","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib559","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.7150\/thno.60851","article-title":"Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment","volume":"11","author":"Hong","year":"2021","journal-title":"Theranostics"},{"issue":"30","key":"10.1016\/j.mmr.2026.100047_bib560","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401876","article-title":"Rapid biofabrication of an advanced microphysiological system mimicking phenotypical heterogeneity and drug resistance in glioblastoma","volume":"13","author":"Pun","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib561","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.2024.10613","article-title":"Ivonescimab plus chemotherapy in non-small cell lung cancer with EGFR variant: a randomized clinical trial","volume":"332","author":"Investigators","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib562","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jtho.2021.09.014","article-title":"Impower150 final exploratory analyses for atezolizumab plus bevacizumab and chemotherapy in key NSCLC patient subgroups with EGFR mutations or metastases in the liver or brain","volume":"17","author":"Nogami","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib563","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006127","article-title":"First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817","volume":"11","author":"Ready","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib564","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib565","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/noy032","article-title":"Car T-cell therapy for glioblastoma: recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib566","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jtho.2021.07.035","article-title":"Brigatinib versus crizotinib in ALK inhibitor-naive advanced ALK-positive NSCLC: final results of phase 3 ALTA-1L trial","volume":"16","author":"Camidge","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib567","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2213-2600(22)00437-4","article-title":"Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib568","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.23.02219","article-title":"CNS efficacy of osimertinib with or without chemotherapy in epidermal growth factor receptor-mutated advanced non-small-cell lung cancer","volume":"42","author":"J\u00e4nne","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib569","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/neuonc\/noaa281","article-title":"Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase \u2162 trial","volume":"23","author":"Yang","year":"2021","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib570","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ccell.2021.07.005","article-title":"Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): a multicenter phase 3 study","volume":"39","author":"Zhou","year":"2021","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib571","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1470-2045(22)00382-5","volume":"23","author":"Lu","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib572","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35864","article-title":"Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 \u226550%","volume":"131","author":"Kilickap","year":"2025","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib573","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jtho.2023.04.021","article-title":"Systemic and intracranial outcomes with first-line nivolumab plus ipilimumab in patients with metastatic NSCLC and baseline brain metastases from CheckMate 227 part 1","volume":"18","author":"Reck","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"28","key":"10.1016\/j.mmr.2026.100047_bib574","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase \u2162 trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib575","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib576","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13014-023-02216-5","article-title":"Radiosurgery of limited brain metastases from primary solid tumor: Results of the randomized phase \u2162 trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform","volume":"18","author":"Scorsetti","year":"2023","journal-title":"Radiat Oncol"},{"issue":"17","key":"10.1016\/j.mmr.2026.100047_bib577","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1158\/1078-0432.CCR-21-1046","article-title":"Primary analysis and 4-year follow-up of the phase \u2162 NIBIT-M2 trial in melanoma patients with brain metastases","volume":"27","author":"Di Giacomo","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib578","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102924","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial","volume":"9","author":"Hurvitz","year":"2024","journal-title":"ESMO Open"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib579","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jamaoncol.2022.5049","volume":"8","author":"Palmer","year":"2022","journal-title":"JAMA Oncol"},{"issue":"20","key":"10.1016\/j.mmr.2026.100047_bib580","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in ret fusion-positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.mmr.2026.100047_bib581","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1200\/JCO.21.02278","article-title":"Post hoc analysis of lorlatinib intracranial efficacy and safety in patients with ALK-positive advanced non-small-cell lung cancer from the phase \u2162 CROWN study","volume":"40","author":"Solomon","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib582","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jamaoncol.2021.3523","article-title":"Ensartinib vs crizotinib for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer: a randomized clinical trial","volume":"7","author":"Horn","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib583","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41392-023-01538-w","article-title":"Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase \u2162 trial","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib584","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-024-01927-9","article-title":"Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase \u2162 trial","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib585","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.09.002","article-title":"First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: the phase 3 everest trial","volume":"6","author":"Zhou","year":"2025","journal-title":"Med"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib586","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/cac2.12594","article-title":"Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase \u2162 trial (AENEAS)","volume":"44","author":"Lu","year":"2024","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib587","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55050","article-title":"Gefitinib plus chemotherapy vs gefitinib alone in untreated EGFR-mutant non-small cell lung cancer in patients with brain metastases: The gap brain open-label, randomized, multicenter, phase 3 study","volume":"6","author":"Hou","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mmr.2026.100047_bib588","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110334","article-title":"Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: results & reflections from the prematurely closed phase \u2162 hybrid trial","volume":"197","author":"Zeng","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib589","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113531","article-title":"Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase \u2162 NIBIT-M2 trial","volume":"199","author":"Di Giacomo","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.mmr.2026.100047_bib590","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejca.2022.07.035","article-title":"An open label, non-randomised, phase \u2162b study of trametinib in combination with dabrafenib in patients with unresectable (stage \u2162) or distant metastatic (stage \u2163) BRAF V600-mutant melanoma: a subgroup analysis of patients with brain metastases","volume":"175","author":"Dutriaux","year":"2022","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib591","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamaoncol.2022.0514","article-title":"Treatment with etirinotecan pegol for patients with metastatic breast cancer and brain metastases: final results from the phase 3 attain randomized clinical trial","volume":"8","author":"Tripathy","year":"2022","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib592","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-mutant low-grade glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"ement_2","key":"10.1016\/j.mmr.2026.100047_bib593","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/neuonc\/noae031","article-title":"ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma","volume":"26","author":"Arrillaga-Romany","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib594","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53285","article-title":"Adjuvant temozolomide chemotherapy with or without interferon \u03b1 among patients with newly diagnosed high-grade gliomas: a randomized clinical trial","volume":"6","author":"Guo","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib595","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/1078-0432.CCR-21-4283","article-title":"Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post hoc analysis of the eortc randomized phase \u2162 catnon trial","volume":"28","author":"Tesileanu","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib596","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/neuonc\/noaa168","article-title":"Codel: phase \u2162 study of RT, RT+TMZ, or TMZ for newly diagnosed 1p\/19q codeleted oligodendroglioma. Analysis from the initial study design","volume":"23","author":"Jaeckle","year":"2021","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib597","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/neuonc\/noae053","article-title":"Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial","volume":"26","author":"Roth","year":"2024","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib598","first-page":"339","article-title":"Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma","volume":"25","author":"Lassman","year":"2023","journal-title":"a phase \u2162 randomized clinical trial. Neuro Oncol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib599","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4149","article-title":"Effect of disulfiram and copper plus chemotherapy vs chemotherapy alone on survival in patients with recurrent glioblastoma: a randomized clinical trial","volume":"6","author":"Werlenius","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib600","first-page":"123","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated mgmt promoter","volume":"25","author":"Omuro","year":"2023","journal-title":"an international randomized phase \u2162 trial. Neuro Oncol"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib601","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.20.02730","article-title":"Children's oncology group phase \u2162 trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"39","author":"Michalski","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib602","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/neuonc\/noac246","article-title":"Randomized phase \u2162 study of high-dose methotrexate and whole-brain radiotherapy with\/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C","volume":"25","author":"Mishima","year":"2023","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib603","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.34016","article-title":"Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920","volume":"128","author":"Emamekhoo","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.mmr.2026.100047_bib604","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118689","article-title":"Unveiling the antitumor mechanism of 7\u03b1-acetoxy-6\u03b2-hydroxyroyleanone from Plectranthus hadiensis in glioblastoma","volume":"335","author":"Magalh\u00e3es","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib605","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10585-025-10328-3","article-title":"Repurposing neuroleptics: clozapine as a novel, adjuvant therapy for melanoma brain metastases","volume":"42","author":"Wikerholmen","year":"2025","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.mmr.2026.100047_bib606","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155611","article-title":"Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression","volume":"130","author":"Zong","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mmr.2026.100047_bib607","article-title":"situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response","volume":"26","author":"Chellen","year":"2024","journal-title":"Mater Today Bio"},{"issue":"28","key":"10.1016\/j.mmr.2026.100047_bib608","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib609","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175033","article-title":"Sting agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma","volume":"134","author":"Najem","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mmr.2026.100047_bib610","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2024.07.004","article-title":"Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment","volume":"373","author":"Lee","year":"2024","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib611","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1038\/s41467-024-48326-w","article-title":"Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas","volume":"15","author":"Arrieta","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib612","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1021\/acsnano.1c09601","article-title":"Rabies virus glycoprotein-mediated transportation and T cell infiltration to brain tumor by magnetoelectric gold yarnballs","volume":"16","author":"Cheng","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib613","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib614","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1021\/acsnano.4c18056","article-title":"EXO(TLR1\/2-STING): a dual-mechanism stimulator of interferon genes activator for cancer immunotherapy","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib615","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202512104","article-title":"A sono-responsive nanoplatform integrating STING activation and CXCR4 blockade for synergistic immunotherapy of glioblastoma","volume":"38","author":"Kang","year":"2026","journal-title":"Adv Mater"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib616","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00262-024-03818-y","article-title":"Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma","volume":"73","author":"Quinn","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib617","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-21-3324","article-title":"Convection enhanced delivery of the oncolytic adenovirus \u03b424-RGD in patients with recurrent GBM: a phase \u2160 clinical trial including correlative studies","volume":"28","author":"van Putten","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib618","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41467-024-55455-9","article-title":"Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the il6ra-bcl6 axis for targeted control of glioblastoma","volume":"16","author":"Grimes","year":"2025","journal-title":"Nat Commun"},{"issue":"7985","key":"10.1016\/j.mmr.2026.100047_bib619","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib620","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","article-title":"A phase \u2160\/\u2161 study of triple-mutated oncolytic herpes virus G47\u2206 in patients with progressive glioblastoma","volume":"13","author":"Todo","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib621","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib622","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1470-2045(21)00245-X","article-title":"Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial","volume":"22","author":"Fares","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib623","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1038\/s41467-024-53041-7","article-title":"Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: A phase \u2160 trial","volume":"15","author":"Ning","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib624","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41467-023-43076-7","article-title":"Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: A phase 1 trial","volume":"15","author":"Galanis","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib625","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S1470-2045(23)00347-9","article-title":"Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial","volume":"24","author":"Umemura","year":"2023","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib626","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41591-023-02347-y","article-title":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: A phase 1\/2 trial","volume":"29","author":"Nassiri","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib627","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008880","article-title":"Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival","volume":"12","author":"Bommareddy","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"682","key":"10.1016\/j.mmr.2026.100047_bib628","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn5649","article-title":"Immunotoxin-\u03b1CD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models","volume":"15","author":"Parker","year":"2023","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib629","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/neuonc\/noae105","article-title":"Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy","volume":"26","author":"Noh","year":"2024","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib630","first-page":"965","article-title":"Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma","volume":"19","author":"Reardon","year":"2017","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib631","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/neuonc\/nox202","article-title":"Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma","volume":"20","author":"Gan","year":"2018","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib632","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2967\/jnumed.120.253146","article-title":"A phase 1 and biodistribution study of abt-806i, an (111)in-radiolabeled conjugate of the tumor-specific anti-EGFR antibody abt-806","volume":"62","author":"Gan","year":"2021","journal-title":"Journal of nuclear medicine: official publication, Society of Nuclear Medicine"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib633","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/s41467-024-50558-9","article-title":"Sacituzumab govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial","volume":"15","author":"Balinda","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.mmr.2026.100047_bib634","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107957","article-title":"Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis","volume":"196","author":"Zheng","year":"2024","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib635","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/neuonc\/noac195","article-title":"A phase \u2160\/\u2161 study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: safety, efficacy, and cerebrospinal fluid pharmacokinetics","volume":"25","author":"Kumthekar","year":"2023","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib636","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105059","article-title":"Novel trop2 antibody-drug conjugates for treatment of HER2-negative metastatic breast cancer patients with brain metastases: a promising option\u2606","volume":"10","author":"Wang","year":"2025","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib637","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S1470-2045(25)00465-6","article-title":"Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial","volume":"26","author":"Fuereder","year":"2025","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib638","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S1470-2045(25)00470-X","article-title":"Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial","volume":"26","author":"Bartsch","year":"2025","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib639","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.trecan.2024.07.002","article-title":"Bispecific antibodies: advancing precision oncology","volume":"10","author":"Herrera","year":"2024","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib640","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.2024024168","article-title":"Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma","volume":"144","author":"Godfrey","year":"2024","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib641","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jtho.2025.02.023","article-title":"Rapid intracranial response with tarlatamab in patients with untreated brain metastases from SCLC-a real-world case series: case report","volume":"20","author":"Zhang","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib642","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acsnano.4c05906","article-title":"pH-responsive polyethylene glycol engagers for enhanced brain delivery of PEGylated nanomedicine to treat glioblastoma","volume":"19","author":"Meng","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib643","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1038\/s41467-024-51315-8","article-title":"A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine","volume":"15","author":"Latzer","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib644","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13073-024-01281-z","article-title":"Mrna-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors","volume":"16","author":"Trivedi","year":"2024","journal-title":"Genome Med"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib645","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1158\/1078-0432.CCR-21-2867","article-title":"A phase \u2160 study of autologous dendritic cell vaccine pulsed with allogeneic stem-like cell line lysate in patients with newly diagnosed or recurrent glioblastoma","volume":"28","author":"Hu","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib646","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1200\/JCO.20.01892","article-title":"Survival impact of anti-GD2 antibody response in a phase \u2161 ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression","volume":"39","author":"Cheung","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib647","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202511351","article-title":"Preventing glioblastoma relapse by igniting innate immunity through mitochondrial stress in the surgical cavity","volume":"38","author":"Han","year":"2026","journal-title":"Adv Mater"},{"issue":"33","key":"10.1016\/j.mmr.2026.100047_bib648","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202420630","article-title":"Intranasal and intravenous sequential administration of survivin peptide-CpG nanovaccines elicits potent immunity toward glioblastoma","volume":"37","author":"Shi","year":"2025","journal-title":"Adv Mater"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib649","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00262-024-03837-9","article-title":"PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis","volume":"73","author":"Blobner","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib650","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-024-03027-6","article-title":"Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening","volume":"43","author":"Li","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib651","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00262-024-03808-0","article-title":"Antitumor effects of intracranial injection of B7-H3-targeted CAR-T and CAR-NK cells in a patient-derived glioblastoma xenograft model","volume":"73","author":"Tachi","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib652","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","article-title":"Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety","volume":"13","author":"Vitanza","year":"2023","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib653","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2024.11.010","article-title":"Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy","volume":"32","author":"Logun","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"8046","key":"10.1016\/j.mmr.2026.100047_bib654","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib655","doi-asserted-by":"crossref","first-page":"742","DOI":"10.21147\/j.issn.1000-9604.2025.05.07","article-title":"Advances in integrating biomaterials with CAR-T cells for enhancing solid tumor therapy","volume":"37","author":"Huang","year":"2025","journal-title":"Chin J Cancer Res"},{"issue":"591","key":"10.1016\/j.mmr.2026.100047_bib656","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mmr.2026.100047_bib657","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01533-2","article-title":"Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence","author":"Kaiser","year":"2025","journal-title":"Nat Biomed Eng"},{"issue":"805","key":"10.1016\/j.mmr.2026.100047_bib658","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado9511","article-title":"A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice","volume":"17","author":"Rossari","year":"2025","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib659","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.immuni.2025.07.018","article-title":"Mechanical signaling via \u03b22 integrin decouples T cell proliferation and differentiation for generating stem cell-like CAR T cells","volume":"58","author":"Lv","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.mmr.2026.100047_bib660","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217541","article-title":"The development and potent antitumor efficacy of CD44\/CD133 dual-targeting il7r\u03b1-armored CAR-T cells against glioblastoma","volume":"614","author":"Zhai","year":"2025","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib661","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/2326-6066.CIR-23-1094","article-title":"PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma","volume":"12","author":"Martinez Bedoya","year":"2024","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib662","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009403","article-title":"EphA3 CAR T cells are effective against glioblastoma in preclinical models","volume":"12","author":"Martins","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib663","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib664","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib665","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of il-13r\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib666","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib667","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/neuonc\/noac024","article-title":"Off-the-shelf, steroid-resistant, IL13R\u03b12-specific CAR T cells for treatment of glioblastoma","volume":"24","author":"Brown","year":"2022","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib668","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s43018-023-00709-6","article-title":"Repeated peripheral infusions of anti-EGFRv\u2162 CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial","volume":"5","author":"Bagley","year":"2024","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib669","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s43018-025-00905-6","article-title":"FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy","volume":"6","author":"Ni","year":"2025","journal-title":"Nat Cancer"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib670","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1158\/1078-0432.CCR-23-1880","article-title":"GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma","volume":"30","author":"Ciccone","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib671","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.stem.2020.04.008","article-title":"The rational development of CD133-targeting immunotherapies for glioblastoma","volume":"26","author":"Vora","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib672","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.brs.2025.07.014","article-title":"Tumor treating fields combined with ionizing radiation inhibit the malignant phenotype of lung cancer brain metastasis cells by suppressing DNA damage repair pathways","volume":"18","author":"Tanzhu","year":"2025","journal-title":"Brain Stimul"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib673","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12967-023-04089-4","article-title":"Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis","volume":"21","author":"Tian","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib674","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41420-022-01206-y","article-title":"The schemes, mechanisms and molecular pathway changes of tumor treating fields (TTFfields) alone or in combination with radiotherapy and chemotherapy","volume":"8","author":"Tanzhu","year":"2022","journal-title":"Cell Death Discov"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib675","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib676","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009449","article-title":"Inhibitory fcgamma receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma","volume":"12","author":"Ku","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib677","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41416-025-02977-8","article-title":"CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma","volume":"132","author":"Strassheimer","year":"2025","journal-title":"Br J Cancer"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib678","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1158\/0008-5472.CAN-21-3656","article-title":"CDK4\/6 inhibition enhances oncolytic virus efficacy by potentiating tumor-selective cell killing and T-cell activation in refractory glioblastoma","volume":"82","author":"Xiao","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.mmr.2026.100047_bib679","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217133","article-title":"Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.mmr.2026.100047_bib680","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137751","article-title":"Brain-targeted polymersomes mediating RNAi of STAT3 sensitize glioblastoma to temozolomide and immunotherapy","volume":"695","author":"Xia","year":"2025","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib681","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/s41467-025-57906-3","article-title":"Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer","volume":"16","author":"Deng","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.mmr.2026.100047_bib682","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.974156","article-title":"Emerging role of ferroptosis in glioblastoma: therapeutic opportunities and challenges","volume":"9","author":"Zhuo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.mmr.2026.100047_bib683","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.actbio.2024.11.042","article-title":"A metal coordination polymer nanoparticle synergistically re-establishes acidosis and enhances chemodynamic therapy for glioblastoma","volume":"192","author":"Chi","year":"2025","journal-title":"Acta Biomater"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib684","article-title":"Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma","volume":"5","author":"Zhong","year":"2024","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib685","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21147\/j.issn.1000-9604.2025.01.02","article-title":"Ct-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: a multicenter study","volume":"37","author":"Yin","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.mmr.2026.100047_bib686","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112144","article-title":"Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor","volume":"143","author":"Kang","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"29","key":"10.1016\/j.mmr.2026.100047_bib687","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400502","article-title":"Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"issue":"30","key":"10.1016\/j.mmr.2026.100047_bib688","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400630","article-title":"A targeted and responsive nanoprodrug delivery system for synergistic glioma chemotherapy","volume":"20","author":"Zhuo","year":"2024","journal-title":"Small"},{"issue":"46","key":"10.1016\/j.mmr.2026.100047_bib689","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303073","article-title":"Drug repurposing-based brain-targeting self-assembly nanoplatform using enhanced ferroptosis against glioblastoma","volume":"19","author":"Liang","year":"2023","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib690","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1021\/jacs.2c13701","article-title":"Homotypic membrane-enhanced blood-brain barrier crossing and glioblastoma targeting for precise surgical resection and photothermal therapy","volume":"145","author":"Zhang","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mmr.2026.100047_bib691","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102838","article-title":"Wireless chargeable gold Yarnball-mediated mitochondrial depolarization for dendritic cell detainment in programmed brain tumor immunotherapy","volume":"65","author":"Moorthy","year":"2025","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib692","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406178","article-title":"A self-cascading catalytic therapy and antigen capture scaffold-mediated T cells augments for postoperative brain immunotherapy","volume":"21","author":"Yalamandala","year":"2025","journal-title":"Small"},{"issue":"23","key":"10.1016\/j.mmr.2026.100047_bib693","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.1021\/acsnano.3c09273","article-title":"Layer-by-layer polymer functionalization improves nanoparticle penetration and glioblastoma targeting in the brain","volume":"17","author":"Pickering","year":"2023","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib694","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1039\/C9TB02341K","article-title":"Albumin-stabilized manganese-based nanocomposites with sensitive tumor microenvironment responsivity and their application for efficient siRNA delivery in brain tumors","volume":"8","author":"Xu","year":"2020","journal-title":"J Mater Chem B"},{"issue":"28","key":"10.1016\/j.mmr.2026.100047_bib695","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1021\/acsnano.4c06183","article-title":"A self-cascade penetrating brain tumor immunotherapy mediated by near-infrared \u2161 cell membrane-disrupting nanoflakes via detained dendritic cells","volume":"18","author":"Yalamandala","year":"2024","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.mmr.2026.100047_bib696","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304331","article-title":"Ultrasound-activated piezoelectric nanoparticles trigger microglia activity against glioblastoma cells","volume":"13","author":"Montorsi","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.mmr.2026.100047_bib697","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120435","article-title":"Transferrin-modified nanoparticles for targeted delivery of asiatic acid to glioblastoma cells","volume":"296","author":"Ramalho","year":"2022","journal-title":"Life Sci"},{"issue":"22","key":"10.1016\/j.mmr.2026.100047_bib698","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202008802","article-title":"Upregulating aggregation-induced-emission nanoparticles with blood-tumor-barrier permeability for precise photothermal eradication of brain tumors and induction of local immune responses","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv Mater"},{"issue":"13","key":"10.1016\/j.mmr.2026.100047_bib699","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202411869","article-title":"Self-oxygenating PROTAC microneedle for spatiotemporally-confined protein degradation and enhanced glioblastoma therapy","volume":"37","author":"Jiang","year":"2025","journal-title":"Adv Mater"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib700","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","article-title":"Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib701","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","article-title":"Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide antigen-captured nanosponge for remotely enhancing lung metastasis immunotherapy","volume":"19","author":"Chiang","year":"2025","journal-title":"ACS Nano"},{"issue":"27","key":"10.1016\/j.mmr.2026.100047_bib702","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","article-title":"Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation","volume":"19","author":"Huynh","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mmr.2026.100047_bib703","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2021.04.021","article-title":"Theranostic aguix nanoparticles as radiosensitizer: a phase \u2160, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)","volume":"160","author":"Verry","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib704","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.mmr.2026.100047_bib705","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400421","article-title":"A manganese-based nanodriver coordinates tumor prevention and suppression through STING activation in glioblastoma","volume":"13","author":"Zhang","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib706","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jamaoncol.2024.2640","article-title":"Lazertinib in EGFR-variant non-small cell lung cancer with CNS failure to prior EGFR tyrosine kinase inhibitors: a nonrandomized controlled trial","volume":"10","author":"Hong","year":"2024","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib707","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102068","article-title":"Dacomitinib in EGFR-mutant non-small-cell lung cancer with brain metastasis: a single-arm, phase \u2161 study","volume":"8","author":"Jung","year":"2023","journal-title":"ESMO Open"},{"issue":"23","key":"10.1016\/j.mmr.2026.100047_bib708","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.24.00708","article-title":"Phase \u2161 efficacy and safety of 80 mg osimertinib in patients with leptomeningeal metastases associated with epidermal growth factor receptor mutation-positive non-small cell lung cancer (BLOSSOM)","volume":"42","author":"Park","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib709","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2022.03.016","article-title":"Phase \u2160 study of trametinib in combination with whole brain radiation therapy for brain metastases","volume":"170","author":"Palmer","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib710","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2401618","article-title":"A phase \u2161 study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases","volume":"56","author":"Gu","year":"2024","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib711","first-page":"478","article-title":"Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases","volume":"23","author":"Yang","year":"2021","journal-title":"a phase \u2161 blinded randomized trial. Neuro Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib712","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2021.02.044","article-title":"Prophylactic cranial irradiation reduces brain metastases and improves overall survival in high-risk metastatic non-small cell lung cancer patients: a randomized phase 2 study (PRoT-BM trial)","volume":"110","author":"Arrieta","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib713","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3171\/2024.2.JNS232426","article-title":"Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency","volume":"141","author":"Mallela","year":"2024","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib714","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/neuonc\/noaa152","article-title":"Clinical trial of proton craniospinal irradiation for leptomeningeal metastases","volume":"23","author":"Yang","year":"2021","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib715","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102384","article-title":"Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase \u2161 clinical trial","volume":"9","author":"Fan","year":"2024","journal-title":"ESMO Open"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib716","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jtho.2023.01.083","article-title":"Efficacy, safety, and health-related quality of life with camrelizumab plus pemetrexed and carboplatin as first-line treatment for advanced nonsquamous NSCLC with brain metastases (CAP-BRAIN): a multicenter, open-label, single-arm, phase 2 study","volume":"18","author":"Hou","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib717","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijrobp.2023.07.019","article-title":"Concurrent lapatinib with brain radiation therapy in patients with HER2+ breast cancer with brain metastases: NRG oncology-KROG\/RTOG 1119 phase 2 randomized trial","volume":"118","author":"Kim","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib718","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2023.5791","article-title":"Brain radiotherapy with pyrotinib and capecitabine in patients with erbb2-positive advanced breast cancer and brain metastases: a nonrandomized phase 2 trial","volume":"10","author":"Yang","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib719","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(21)00716-6","article-title":"Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial","volume":"23","author":"Yan","year":"2022","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib720","first-page":"2074","article-title":"Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN\/GEM1802 phase \u2161 study). Neuro Oncol","volume":"26","author":"M\u00e1rquez-Rodas","year":"2024"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib721","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(24)00735-6","article-title":"Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study","volume":"26","author":"Long","year":"2025","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.mmr.2026.100047_bib722","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1158\/1078-0432.CCR-21-0800","article-title":"Intracranial efficacy of selpercatinib in RET fusion-positive non-small cell lung cancers on the LIBRETTO-001 trial","volume":"27","author":"Subbiah","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib723","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.jtho.2021.07.026","article-title":"A phase \u2161 study of osimertinib for radiotherapy-naive central nervous system metastasis from NSCLC: results for the T790M cohort of the OCEAN study (LOGIK1603\/WJJOG9116L).","volume":"16","author":"Yamaguchi","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib724","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1078-0432.CCR-24-2350","article-title":"Phase \u2160\/\u2161 investigator-initiated study of olaparib and temozolomide in SCLC: final analysis and CNS outcomes","volume":"31","author":"Meador","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib725","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/neuonc\/noab087","article-title":"MEVITEM-a phase \u2160\/\u2161 trial of vismodegib+temozolomide vs temozolomide in patients with recurrent\/refractory medulloblastoma with sonic hedgehog pathway activation","volume":"23","author":"Frappaz","year":"2021","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib726","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/neuonc\/noae201","article-title":"Stereotactic radiosurgery for 1\u201310 brain metastases to avoid whole-brain radiotherapy: results of the CYBER-SPACE randomized phase 2 trial","volume":"27","author":"El Shafie","year":"2025","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib727","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/neuonc\/noae076","article-title":"Phase \u2160 trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases","volume":"26","author":"Murphy","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib728","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1038\/s41467-024-53034-6","article-title":"Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates","volume":"15","author":"Jansen","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib729","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijrobp.2022.02.010","article-title":"Nitroglycerin plus whole intracranial radiation therapy for brain metastases in patients with non-small cell lung cancer: a randomized, open-label, phase 2 clinical trial","volume":"115","author":"Arrieta","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib730","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/oncolo\/oyad013","article-title":"Ramucirumab plus docetaxel for patients with non-small cell lung cancer with brain metastases: a multicenter, open-label single-arm phase \u2161 trial","volume":"28","author":"Tanimura","year":"2023","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib731","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006871","article-title":"Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase \u2160\/\u2161 trial","volume":"11","author":"Altan","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"28","key":"10.1016\/j.mmr.2026.100047_bib732","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1200\/JCO.22.02561","article-title":"Phase \u2161 trial of atezolizumab combined with carboplatin and pemetrexed for patients with advanced nonsquamous non-small-cell lung cancer with untreated brain metastases (atezo-brain, GECP17\/05)","volume":"41","author":"Nadal","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib733","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41591-023-02392-7","article-title":"Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results","volume":"29","author":"Brastianos","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib734","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011432","article-title":"Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase \u2160b study","volume":"13","author":"Ahmed","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"33","key":"10.1016\/j.mmr.2026.100047_bib735","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized phase \u2161 trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib736","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/S1470-2045(21)00545-3","article-title":"Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study","volume":"22","author":"Tawbi","year":"2021","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.mmr.2026.100047_bib737","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO-24-02219","article-title":"Phase \u2161 trial of pembrolizumab in combination with bevacizumab for untreated melanoma brain metastases","volume":"43","author":"Weiss","year":"2025","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib738","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/neuonc\/noac155","article-title":"The first-in-human phase \u2160 study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas","volume":"25","author":"Natsume","year":"2023","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib739","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noac263","article-title":"Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: a phase \u2160, \"window-of-opportunity\" study","volume":"25","author":"Moreno","year":"2023","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib740","article-title":"A multicenter, phase 1, adult brain tumor consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)","volume":"5","author":"Ahluwalia","year":"2024","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib741","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41416-023-02356-1","article-title":"A phase 1\/2a trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma","volume":"129","author":"Lopez","year":"2023","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib742","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1158\/1078-0432.CCR-21-2225","article-title":"A phase \u2161 study of the efficacy and safety of oral selinexor in recurrent glioblastoma","volume":"28","author":"Lassman","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib743","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1470-2045(21)00578-7","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600E)-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial","volume":"23","author":"Wen","year":"2022","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib744","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2024.01.011","article-title":"Concurrent olaparib and radiation therapy in older patients with newly diagnosed glioblastoma: the phase 1 dose-escalation PARADIGM trial","volume":"118","author":"Derby","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib745","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-24-2974","article-title":"Olaparib, temozolomide, and concomitant radiotherapy for partially resected or biopsy-only glioblastoma first-line treatment: results from the OLA-TMZ-RTE-01 phase \u2160 study","volume":"31","author":"Stefan","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mmr.2026.100047_bib746","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2020.09.036","article-title":"Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma","volume":"154","author":"Biau","year":"2021","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib747","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.22.00996","article-title":"Phase \u2161a study of SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma","volume":"41","author":"Ahluwalia","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib748","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ijrobp.2024.01.013","article-title":"Prospective randomized phase 2 trial of hypofractionated stereotactic radiation therapy of 25 Gy in 5 fractions compared with 35 Gy in 5 fractions in the reirradiation of recurrent glioblastoma","volume":"119","author":"Chen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.mmr.2026.100047_bib749","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2021.12.019","article-title":"Re-irradiation for recurrent high grade glioma (HGG) patients: results of a single arm prospective phase 2 study","volume":"167","author":"Navarria","year":"2022","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib750","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/neuonc\/noab040","article-title":"A prospective phase \u2161 randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma","volume":"23","author":"Brown","year":"2021","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib751","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/neuonc\/noac253","article-title":"Phase \u2160 study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity","volume":"25","author":"Dean","year":"2023","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib752","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54326-7","article-title":"Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort","volume":"15","author":"McFaline-Figueroa","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib753","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002296","article-title":"Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase \u2160 clinical trial","volume":"9","author":"Duerinck","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib754","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/neuonc\/noae177","article-title":"Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma","volume":"26","author":"Duerinck","year":"2024","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib755","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1158\/1078-0432.CCR-23-3341","article-title":"A phase 0\/\u2160 pharmacokinetic and pharmacodynamics and safety and tolerability study of letrozole in combination with standard therapy in recurrent high-grade gliomas","volume":"30","author":"Desai","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib756","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-023-01835-6","article-title":"Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial","volume":"22","author":"Bos","year":"2023","journal-title":"Mol Cancer"},{"issue":"16","key":"10.1016\/j.mmr.2026.100047_bib757","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-21-0611","article-title":"Vorasidenib, a dual inhibitor of mutant IDH1\/2, in recurrent or progressive glioma; results of a first-in-human phase \u2160 trial","volume":"27","author":"Mellinghoff","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib758","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41591-022-02141-2","article-title":"Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial","volume":"29","author":"Mellinghoff","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib759","first-page":"146","article-title":"Olutasidenib (ft-2102) in patients with relapsed or refractory IDH1-mutant glioma: a multicenter, open-label, phase \u2160b\/\u2161 trial. Neuro Oncol","volume":"25","author":"de la Fuente","year":"2023"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib760","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/1078-0432.CCR-21-2664","article-title":"Infigratinib in patients with recurrent gliomas and FGFR alterations: a multicenter phase \u2161 study","volume":"28","author":"Lassman","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib761","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/neuonc\/noab111","article-title":"A randomized phase \u2161 trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study","volume":"23","author":"Sim","year":"2021","journal-title":"Neuro Oncol"},{"issue":"15","key":"10.1016\/j.mmr.2026.100047_bib762","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1158\/1078-0432.CCR-23-4098","article-title":"Evaluating the base excision repair inhibitor TRC102 and temozolomide for patients with recurrent glioblastoma in the phase 2 adult brain tumor consortium trial BERT","volume":"30","author":"Ahluwalia","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib763","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jamaoncol.2024.4361","article-title":"Efficacy of adding veliparib to temozolomide for patients with MGMT-methylated glioblastoma: a randomized clinical trial","volume":"10","author":"Sarkaria","year":"2024","journal-title":"JAMA Oncol"},{"issue":"13","key":"10.1016\/j.mmr.2026.100047_bib764","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase \u2161 investigation of TVB-2640 (denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib765","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.33378","article-title":"Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial","volume":"127","author":"Reardon","year":"2021","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib766","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/neuonc\/noae058","article-title":"NRG-BN002: phase \u2160 study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma","volume":"26","author":"Sloan","year":"2024","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib767","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oncolo\/oyad095","article-title":"Hypofractionated stereotactic re-irradiation and anti-PDL1 durvalumab combination in recurrent glioblastoma: STERIMGLI phase \u2160 results","volume":"28","author":"Pouessel","year":"2023","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib768","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/s41467-024-48416-9","article-title":"L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: Dose escalation of the phase \u2160\/\u2161 GLORIA trial","volume":"15","author":"Giordano","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib769","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/1078-0432.CCR-24-1629","article-title":"Re-irradiation plus pembrolizumab: a phase \u2161 study for patients with recurrent glioblastoma","volume":"31","author":"Iwamoto","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib770","first-page":"951","article-title":"Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma","volume":"24","author":"Chiocca","year":"2022","journal-title":"an open-label, multi-institutional phase \u2160 trial. Neuro Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100047_bib771","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1078-0432.CCR-20-3805","article-title":"Phase \u2160b clinical trial of IGV-001 for patients with newly diagnosed glioblastoma","volume":"27","author":"Andrews","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib772","first-page":"677","article-title":"Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas","volume":"23","author":"Sahebjam","year":"2021","journal-title":"results from a phase \u2160 study. Neuro Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib773","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/1078-0432.CCR-20-2500","article-title":"Randomized phase \u2161 and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for patients with recurrent glioblastoma","volume":"27","author":"Nayak","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mmr.2026.100047_bib774","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2021.12.009","article-title":"Chemoradiotherapy with temozolomide vs. Radiotherapy alone in patients with IDH wild-type and TERT promoter mutation WHO grade \u2161\/\u2162 gliomas: a prospective randomized study","volume":"167","author":"Qiu","year":"2022","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib775","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S1470-2045(24)00585-0","article-title":"Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial","volume":"25","author":"Vora","year":"2024","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100047_bib776","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1080\/15548627.2020.1816343","article-title":"Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase \u2160B trial","volume":"17","author":"Compter","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.mmr.2026.100047_bib777","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101156","article-title":"Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma","volume":"63","author":"Cao","year":"2025","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib778","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG oncology\/RTOG1205: a randomized phase \u2161 trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma","volume":"41","author":"Tsien","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100047_bib779","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1470-2045(22)00599-X","article-title":"Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial","volume":"23","author":"Spinazzi","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib780","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101141","article-title":"Phase \u2160 clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas","volume":"61","author":"Huang","year":"2025","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib781","first-page":"433","article-title":"Efficacy and safety of anlotinib combined with the stupp regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase \u2161 trial","volume":"21","author":"Lai","year":"2024","journal-title":"Cancer Biol Med"},{"issue":"22","key":"10.1016\/j.mmr.2026.100047_bib782","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1158\/1078-0432.CCR-24-1721","article-title":"A first-in-human phase \u2160 study of BXQ-350, a first-in-class sphingolipid metabolism regulator, in patients with advanced\/recurrent solid tumors or high-grade gliomas","volume":"30","author":"Rixe","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100047_bib783","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1001\/jamaoncol.2023.4437","article-title":"Sustained survival benefit in recurrent medulloblastoma by a metronomic antiangiogenic regimen: a nonrandomized controlled trial","volume":"9","author":"Peyrl","year":"2023","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib784","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol"},{"issue":"584","key":"10.1016\/j.mmr.2026.100047_bib785","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib786","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2024.05.009","article-title":"A phase 1\/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma","volume":"120","author":"Huang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.mmr.2026.100047_bib787","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100851","article-title":"Interdisciplinary care of children with diffuse midline glioma","volume":"35","author":"Coleman","year":"2023","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib788","first-page":"454","article-title":"An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma","volume":"72","author":"Hasanov","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"10.1016\/j.mmr.2026.100047_bib789","first-page":"415","article-title":"The interdisciplinary management of brain metastases","volume":"113","author":"Schmieder","year":"2016","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib790","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2326-6066.CIR-23-0211","article-title":"Single-cell transcriptomics reveals the heterogeneity of the immune landscape of IDH-wild-type high-grade gliomas","volume":"12","author":"Ran","year":"2024","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib791","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","article-title":"Proteogenomic and metabolomic characterization of human glioblastoma","volume":"39","author":"Wang","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib792","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/neuonc\/noad207","article-title":"Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma","volume":"26","author":"DeSisto","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib793","doi-asserted-by":"crossref","first-page":"9898","DOI":"10.1038\/s41598-020-66728-w","article-title":"GlioM&M: web-based tool for studying circulating and infiltrating monocytes and macrophages in glioma","volume":"10","author":"Abels","year":"2020","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib794","article-title":"Predicting survival rates in brain metastases patients from non-small cell lung cancer using radiomic signatures associated with tumor immune heterogeneity","volume":"12","author":"Deng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib795","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1038\/s41467-024-51214-y","article-title":"Multi-omics and pharmacological characterization of patient-derived glioma cell lines","volume":"15","author":"Wu","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib796","article-title":"Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy","volume":"5","author":"Cheng","year":"2024","journal-title":"Cell Rep Med"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib797","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/neuonc\/noaa232","article-title":"Brain metastasis detection using machine learning: a systematic review and meta-analysis","volume":"23","author":"Cho","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.mmr.2026.100047_bib798","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1109\/RBME.2022.3185292","article-title":"Image segmentation for MR brain tumor detection using machine learning: a review","volume":"16","author":"Soomro","year":"2023","journal-title":"IEEE Rev Biomed Eng"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib799","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41540-023-00298-1","article-title":"Growth exponents reflect evolutionary processes and treatment response in brain metastases","volume":"9","author":"Oca\u00f1a-Tienda","year":"2023","journal-title":"NPJ Syst Biol Appl"},{"issue":"10","key":"10.1016\/j.mmr.2026.100047_bib800","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.3390\/s23104693","article-title":"A novel approach for brain tumor classification using an ensemble of deep and hand-crafted features","volume":"23","author":"Kibriya","year":"2023","journal-title":"Sensors (Basel)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib801","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/s41467-023-40999-z","article-title":"Non-invasive assessment of normal and impaired iron homeostasis in the brain","volume":"14","author":"Filo","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib802","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11095-022-03261-7","article-title":"Role of tissue hydraulic permeability in convection-enhanced delivery of nanoparticle-encapsulated chemotherapy drugs to brain tumour","volume":"39","author":"Yang","year":"2022","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib803","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41746-024-01277-4","article-title":"Biologically informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post treatment glioblastoma","volume":"7","author":"Wang","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.mmr.2026.100047_bib804","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giae057","article-title":"Deep learning links localized digital pathology phenotypes with transcriptional subtype and patient outcome in glioblastoma","volume":"13","author":"Roetzer-Pejrimovsky","year":"2024","journal-title":"GigaScience"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib805","article-title":"Prognostic risk stratification of gliomas using deep learning in digital pathology images","volume":"4","author":"Chunduru","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib806","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/bios13030302","article-title":"Brain tumor segmentation and classification from sensor-based portable microwave brain imaging system using lightweight deep learning models","volume":"13","author":"Hossain","year":"2023","journal-title":"Biosensors (Basel)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib807","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.mmr.2026.100047_bib808","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92678.2","article-title":"Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation","volume":"12","author":"Schmassmann","year":"2023","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib809","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","article-title":"Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma","volume":"40","author":"Ravi","year":"2022","journal-title":"Cancer Cell"},{"issue":"8060","key":"10.1016\/j.mmr.2026.100047_bib810","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-025-08735-3","article-title":"Characterization of single neurons reprogrammed by pancreatic cancer","volume":"640","author":"Thiel","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.mmr.2026.100047_bib811","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217666","article-title":"Decoding glioblastoma\u2019s diversity: are neurons part of the game?","volume":"620","author":"Maleszewska","year":"2025","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.mmr.2026.100047_bib812","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mmr.2026.100047_bib813","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molmed.2024.10.014","article-title":"Tertiary lymphoid structures in the central nervous system","volume":"31","author":"Yang","year":"2025","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib814","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189312","article-title":"Tertiary lymphoid structures achieve \u2018cold\u2019 to \u2018hot\u2019 transition by remodeling the cold tumor microenvironment","volume":"1880","author":"Cui","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib815","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","article-title":"Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis","volume":"16","author":"Ma","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib816","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molmed.2024.08.008","article-title":"Exploiting the gut microbiome for brain tumour treatment","volume":"31","author":"Keane","year":"2025","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib817","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41419-024-06481-4","article-title":"RUNX1\/NPM1\/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma","volume":"15","author":"Cui","year":"2024","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.mmr.2026.100047_bib818","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib819","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12967-024-05301-9","article-title":"The tumour microenvironment, treatment resistance and recurrence in glioblastoma","volume":"22","author":"White","year":"2024","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib820","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jcmgh.2023.07.008","article-title":"Deciphering brain metastasis stem cell properties from colorectal cancer highlights specific stemness signature and shared molecular features","volume":"16","author":"Desette","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100047_bib821","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ccell.2020.04.001","article-title":"The glioma stem cell model in the era of single-cell genomics","volume":"37","author":"Suv\u00e0","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.mmr.2026.100047_bib822","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/neuonc\/noae203","article-title":"Chimeric antigen receptor T-cell therapy in patients with malignant glioma-from neuroimmunology to clinical trial design considerations","volume":"27","author":"Gallus","year":"2025","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100047_bib823","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","article-title":"Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100047_bib824","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-pathmechdis-042524-025950","article-title":"Immunopathology of glioblastoma","volume":"21","author":"Li","year":"2026","journal-title":"Annu Rev Pathol"},{"issue":"6726","key":"10.1016\/j.mmr.2026.100047_bib825","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl4237","article-title":"Programming tissue-sensing T cells that deliver therapies to the brain","volume":"386","author":"Simic","year":"2024","journal-title":"Science"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:01:33Z","timestamp":1782486093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2054936926000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":825,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2054936926000610"],"URL":"https:\/\/doi.org\/10.1016\/j.mmr.2026.100047","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances","name":"articletitle","label":"Article Title"},{"value":"Military Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmr.2026.100047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Military Science Publishing House.","name":"copyright","label":"Copyright"}],"article-number":"100047"}}